Gene	Disease	Variant	Effect	Source	Drug	Drug_Class	Evidence Level	PubMed ID	Gene Class	Variant Type
AKT1	---	p.E17K	Sensitive	SageDB	AKT inhibitors	AKT inhibitor	Preclinical	21464312, 17611497, 23134728	Pleckstrin homology domain containing	missense
AKT1	BRCA	p.D3N	Sensitive	CancerDR	AKT inhibitors	AKT inhibitor	Preclinical	23486013	Pleckstrin homology domain containing	missense
AKT1	BRCA	p.E17K	Sensitive	SageDB	AKT inhibitors	AKT inhibitor	Preclinical	21464312, 17611497	Pleckstrin homology domain containing	missense
AKT1	OV	p.E17K	Sensitive	SageDB	AKT inhibitors	AKT inhibitor	Clinical Trials	26351323	Pleckstrin homology domain containing	missense
AKT1	SARC	p.H238Y	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	ASCO 2015 (abstr 11010)	Pleckstrin homology domain containing	missense
AKT1	SKCM	p.Q79K	Resistant	SageDB	BRAF inhibitors	B-Raf inhibitor	Preclinical	24265152	Pleckstrin homology domain containing	missense
AKT2	---	CNA	Sensitive	SageDB	AKT inhibitors	AKT inhibitor	Preclinical	ENA 2014 (abstr 373)	Pleckstrin homology domain containing	NOS
AKT2	COADREAD	p.A139V	Resistant	CancerDR	A443654	AKT inhibitor	Preclinical	23486013	Pleckstrin homology domain containing	missense
AKT3	BRCA	any	Sensitive	SageDB	ATP-competitive AKT inhibitors	AKT inhibitor	Preclinical	22722202	Pleckstrin homology domain containing	Fusion
ALK	---	p.F1174C	Resistant	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	Preclinical	24675041	Receptor Tyrosine Kinases	Fusion
ALK	ALL	p.A348D	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	26032424	Receptor Tyrosine Kinases	Fusion
ALK	ALL	p.F856S	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	26032424	Receptor Tyrosine Kinases	Fusion
ALK	COADREAD	p.P1218S	Resistant	CancerDR	PF2341066	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	Fusion
ALK	COADREAD	p.P1543S	Sensitive	CancerDR	TAE684	LRRK2 kinase inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	Fusion
ALK	COADREAD	p.V1476M	Sensitive	CancerDR	TAE684	LRRK2 kinase inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	Fusion
ALK	DLBC	any	Sensitive	SageDB	crizotinib	c-Met inhibitor	Clinical Trials	24491302	Receptor Tyrosine Kinases	Fusion
ALK	ESCA	p.P157H	Resistant	CancerDR	PF2341066	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	Fusion
ALK	GBM	p.F1174L	Resistant	SageDB	crizotinib	c-Met inhibitor	Preclinical	22072639	Receptor Tyrosine Kinases	Fusion
ALK	GBM	p.F1245C	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	22072639	Receptor Tyrosine Kinases	Fusion
ALK	GBM	p.G1128A	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	22072639	Receptor Tyrosine Kinases	Fusion
ALK	GBM	p.I1171N	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	22072639	Receptor Tyrosine Kinases	Fusion
ALK	GBM	p.R1192P	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	22072639	Receptor Tyrosine Kinases	Fusion
ALK	GBM	p.R1275Q	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	22072639	Receptor Tyrosine Kinases	Fusion
ALK	IMT	any	Sensitive	SageDB	crizotinib	c-Met inhibitor	Case Reports	20979472	Receptor Tyrosine Kinases	Fusion
ALK	LAML	p.C928Y	Resistant	CancerDR	PF2341066	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	CNA	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	any	Sensitive	SageDB	crizotinib, ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	22954507	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.1151in_frame_insT	Sensitive	SageDB	ceritinib	ALK inhibitor	FDA Approved	24670165	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.1151in_frame_insT	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.C1156Y	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.F1174L	Sensitive	SageDB	novel ALK inhibiors	ALK inhibitor	Preclinical	24327273	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.F1174L	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.G1202R	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.G1269A	Sensitive	SageDB	ceritinib	ALK inhibitor	FDA Approved	24670165	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.G1269A	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.I1171T	Sensitive	SageDB	ceritinib	ALK inhibitor	FDA Approved	25228534	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.I1171T	Resistant	SageDB	crizotinib, alectinib	c-Met inhibitor,ALK inhibitor	Case Reports	25228534	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.L1152R	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.L1196M	Sensitive	SageDB	ceritinib	ALK inhibitor	FDA Approved	24670165, 24327273	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.L1196M	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.S1206Y	Sensitive	SageDB	ceritinib	ALK inhibitor	FDA Approved	24670165	Receptor Tyrosine Kinases	Fusion
ALK	LUAD	p.S1206Y	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	22277784	Receptor Tyrosine Kinases	Fusion
ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Receptor Tyrosine Kinases	Fusion
ALK	NSCLC	p.F1174V	Sensitive	PCT	Crizotinib	c-Met inhibitor	Case Reports	24736079	Receptor Tyrosine Kinases	Fusion
ALK	SKCM	p.P379S	Resistant	CancerDR	PF2341066	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	Fusion
ALK	THCA	any	Sensitive	SageDB	crizotinib	c-Met inhibitor	Case Reports	24687827	Receptor Tyrosine Kinases	Fusion
AR	BRCA	Expression	Sensitive	MyCancerGenome	androgen receptor modulators and antagonists	anti-androgen	Clinical Trials	23965901	Nuclear hormone receptors	NOS
AR	COADREAD	p.A52T	Sensitive	CancerDR	PARP1Bical	anti-androgen	Preclinical	23486013	Nuclear hormone receptors	missense
AR	LAML	p.S244L	Resistant	CancerDR	PARP1Bical	anti-androgen	Preclinical	23486013	Nuclear hormone receptors	missense
AR	PRAD	741	Sensitive	SageDB	enzalutamide, ARN-509	anti-androgen	Preclinical	23779130	Nuclear hormone receptors	missense
AR	PRAD	741	Resistant	SageDB	bicalutamide	anti-androgen	Preclinical	12517791	Nuclear hormone receptors	missense
AR	PRAD	Expression	Sensitive		androgen receptor modulators and antagonists	NA	FDA Approved	16014598	Nuclear hormone receptors	NOS
AR	PRAD	Expression	Sensitive	SageDB	next-generation AR antagonists	anti-androgen	Preclinical	23589709, 21859989	Nuclear hormone receptors	NOS
AR	PRAD	p.F876L	Resistant	SageDB	enzalutamide, ARN-509	anti-androgen	Case Reports	23779130	Nuclear hormone receptors	missense
AR	PRAD	p.T877A	Sensitive	SageDB	enzalutamide, ARN-509	anti-androgen	Preclinical	23779130	Nuclear hormone receptors	missense
AR	PRAD	p.T877A	Resistant	SageDB	flutamide	anti-androgen	Case Reports	2260966	Nuclear hormone receptors	missense
ARAF	LUAD	p.S214C	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Case Reports	24569458	TKL	missense
ATIC-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
ATM	COADREAD	p.Q2762R	Sensitive	CancerDR	KU55933	ATM inhibitor	Preclinical	23486013	GO Protein Kinase	missense
ATM	DLBC	CNL	Sensitive	SageDB	DNA-PKc inhibitors	DNA-PK inhibitor	Preclinical	23761041	GO Protein Kinase	NOS
ATM	STAD	Underexpression	Sensitive	SageDB	PARP inhibitors	PARP inhibitor	Clinical Trials	26282658	GO Protein Kinase	NOS
AURKA	---	Expression	Sensitive	SageDB	AURK inhibitors	Aurora kinase inhibitor	Preclinical	22302096	Protein phosphatase 1 regulatory subunits	NOS
AURKA	PRAD	Expression	Sensitive	SageDB	AURK inhibitors	Aurora kinase inhibitor	Preclinical	22389870	Protein phosphatase 1 regulatory subunits	NOS
BCL2	DLBC	CNA	Sensitive	SageDB	BCL2 inhibitors	Bcl-2 inhibitor	Preclinical	22649144	Protein phosphatase 1 regulatory subunits	NOS
BCR-ABL1	---	p.T315I	Resistant	PCT	nilotinib	KIT inhibitor	Preclinical	16772610	Unspecified	Fusion
BCR-ABL1	ALL	any	Sensitive	SageDB	nilotinib	KIT inhibitor	FDA Approved	24650752	Unspecified	Fusion
BCR-ABL1	ALL	p.E255K	Sensitive	SageDB	dasatinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.E25V	Sensitive	SageDB	dasatinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F317L	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F317C	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F317I	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F317V	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F359V	Sensitive	SageDB	dasatinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F35C	Sensitive	SageDB	dasatinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.F35I	Sensitive	SageDB	dasatinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.T315A	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.T315I	Sensitive	PCT	ponatinib	KIT inhibitor	FDA Approved	24180494	Unspecified	Fusion
BCR-ABL1	ALL	p.T315I	Sensitive	SageDB	ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.V299L	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	ALL	p.Y253H	Sensitive	SageDB	dasatinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	any	Sensitive	SageDB	imatinib, dasatinib, nilotinib, bosutinib, ponatinib	KIT inhibitor, Bcr-Abl TKI	FDA Approved	19779040	Unspecified	Fusion
BCR-ABL1	CML	any	Resistant	PCT	imatinib	KIT inhibitor	Clinical Trials	11423618	Unspecified	Fusion
BCR-ABL1	CML	p.E255K	Sensitive	SageDB	dasatinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.E25V	Sensitive	SageDB	dasatinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F317L	Sensitive	SageDB	nilotinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F317C	Sensitive	SageDB	nilotinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F317I	Sensitive	SageDB	nilotinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F317V	Sensitive	SageDB	nilotinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F359V	Sensitive	SageDB	dasatinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F35C	Sensitive	SageDB	dasatinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.F35I	Sensitive	SageDB	dasatinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.T315A	Sensitive	SageDB	nilotinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.T315I	Sensitive	SageDB	ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.T315I	Resistant	PCT	imatinib	KIT inhibitor	Clinical Trials	11853795	Unspecified	Fusion
BCR-ABL1	CML	p.V299L	Sensitive	SageDB	nilotinib, ponatinib	KIT inhibitor	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	CML	p.Y253H	Sensitive	SageDB	dasatinib, bosutinib, ponatinib	KIT inhibitor,Bcr-Abl TKI	FDA Approved	21562040	SH2 domain containing	Fusion
BCR-ABL1	DLBC	p.E810G	Sensitive	CancerDR	Nilotinib	KIT inhibitor	Preclinical	23486013	SH2 domain containing	Fusion
BCR-ABL1	LAML	p.I1146T	Resistant	CancerDR	AZD0530	Bcr-Abl TKI	Preclinical	23486013	SH2 domain containing	Fusion
BCR-ABL1	LAML	p.V587M	Resistant	CancerDR	Dasatinib	KIT inhibitor	Preclinical	23486013	SH2 domain containing	Fusion
BCR-ABL1	PAAD	p.G1079D	Sensitive	CancerDR	Nilotinib	KIT inhibitor	Preclinical	23486013	SH2 domain containing	Fusion
BCR-JAK2	ALL	any	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Preclinical	22897847	Unspecified	Fusion
BCR-PDGFRA	CML	any	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	15034867	Unspecified	Fusion
BCR-RET	CML	any	Sensitive	PCT	sorafenib	Angiogenesis inhibitor	Case Reports	22513837	Unspecified	Fusion
BRAF	BRCA	p.G464V	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	BRCA	p.P74A	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	BRCA	p.V600E	Sensitive	CancerDR	SB590885	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	CLL	p.V600E	Sensitive	SageDB	vemurafenib	B-Raf inhibitor	Case Reports	22621641	TKL	missense
BRAF	COADREAD	p.A712T	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	COADREAD	p.E204L	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	COADREAD	p.N581Y	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	COADREAD	p.V600E	Sensitive	SageDB	BRAF inhibitors + anti-EGFR mAbs +/- PI3K pathway inhibitors	B-Raf inhibitor + EGFR inhibitor/PI3K inhibitor	Clinical Trials	ENA 2014 (abstr 11LBA)	TKL	missense
BRAF	COADREAD	p.V600E	Resistant	SageDB	cetuximab, panitumumab	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739, 21163703, 23325582	TKL	missense
BRAF	GBM	p.V600E	Sensitive	SageDB	BRAF inhibitors	B-Raf inhibitor	Preclinical	22038996, 22586120	TKL	missense
BRAF	GIST	p.V600E	Sensitive	SageDB	dabrafenib	B-Raf inhibitor	Case Reports	23470635, 22608338	TKL	missense
BRAF	LAML	p.V600E	Sensitive	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	LUAD	any	Sensitive	SageDB	sorafenib, MEK inhibitors	Angiogenesis inhibitor,MEK inhibitor	Preclinical	24727320	TKL	Fusion
BRAF	LUAD	p.G466V	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22649091	TKL	missense
BRAF	LUAD	p.G469A	Sensitive	SageDB	EGFR TKIs + MEK inhibitors in EGFR mutant	EGFR inhibitor (1st or 2nd gen) + MEK inhibitor	Preclinical	22773810	TKL	missense
BRAF	LUAD	p.G469A	Resistant	SageDB	EGFR TKIs	EGFR inhibitor (1st or 2nd gen)	Case Reports	22773810	TKL	missense
BRAF	LUAD	p.V600E	Sensitive	SageDB	dabrafenib + trametinib	B-Raf inhibitor + MEK inhibitor	Clinical Trials	ASCO 2015 (abstr 8006)	TKL	missense
BRAF	LUAD	p.V600E	Resistant	SageDB	EGFR TKIs	EGFR inhibitor (1st or 2nd gen)	Case Reports	22773810	TKL	missense
BRAF	LUAD	p.Y472C	Sensitive	SageDB	dasatinib	KIT inhibitor	Case Reports	22649091	TKL	missense
BRAF	MM	p.V600E	Sensitive	SageDB	vemurafenib	B-Raf inhibitor	Case Reports	23612012	TKL	missense
BRAF	NSCLC	p.E375D	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	OV	p.V600E	Sensitive	SageDB	dabrafenib	B-Raf inhibitor	Case Reports	22608338	TKL	missense
BRAF	PRAD	any	Sensitive	SageDB	sorafenib, MEK inhibitors	Angiogenesis inhibitor,MEK inhibitor	Preclinical	20526349	TKL	Fusion
BRAF	PRAD	p.L597R	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	SKCM	597	Sensitive	SageDB	trametinib, MEK inhibitors	MEK inhibitor	Case Reports	22805292, 22798288	TKL	missense
BRAF	SKCM	600	Sensitive	PCT	dabrafenib, RAF inhibitor	B-Raf inhibitor	FDA Approved	25399551	TKL	missense
BRAF	SKCM	any	Sensitive		MEK inhibitors	MEK inhibitor	Clinical Trials	24345920	TKL	Fusion
BRAF	SKCM	any	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Preclinical	23890088	TKL	Fusion
BRAF	SKCM	p.D594G	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Preclinical	18794803	TKL	missense
BRAF	SKCM	p.G469E	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Preclinical	18794803	TKL	missense
BRAF	SKCM	p.K601R	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Case Reports	23248257	TKL	missense
BRAF	SKCM	p.L597R	Sensitive	SageDB	BRAF inhibitors	B-Raf inhibitor	Case Reports	23715574	TKL	missense
BRAF	SKCM	p.L597V	Sensitive	PCT	trametinib, MEK inhibitor	MEK inhibitor	Case Reports	22798288	TKL	missense
BRAF	SKCM	p.V600E	Sensitive	SageDB	vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib	B-Raf inhibitor,MEK inhibitor, B-Raf inhibitor + MEK inhibitor	FDA Approved	25399551	TKL	missense
BRAF	SKCM	p.V600E	Resistant	CancerDR	PLX4720	B-Raf inhibitor	Preclinical	23486013	TKL	missense
BRAF	SKCM	p.V600K	Sensitive	SageDB	trametinib, dabrafenib + trametinib	MEK inhibitor	FDA Approved	25399551	TKL	missense
BRAF	SKCM	p.V600R	Sensitive	SageDB	BRAF inhibitors	B-Raf inhibitor	Clinical Trials	23237741	TKL	missense
BRAF	THCA	p.V600E	Sensitive	SageDB	BRAF inhibitors + MEK inhibitors	B-Raf inhibitor + MEK inhibitor	Clinical Trials	ASCO 2013 (abstr 9029)	TKL	missense
BRCA1	OV	A1623G	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	A1708E	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	CNL	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	27908594	Ring finger proteins	NOS
BRCA1	OV	CNL	Sensitive	SageDB	PARP inhibitors	PARP inhibitor	Preclinical	22392482	Ring finger proteins	NOS
BRCA1	OV	G1706E	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	G1738R	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	G1788V	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	I1766S	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	L1764P	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	M1689R	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	M18T	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	R1495M	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	R1699W	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	S1715R	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	T1685A	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	T1685I	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA1	OV	V1688del	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	in_frame_del
BRCA1	OV	any frameshift mutation	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	27617661; 27908594	Ring finger proteins	frame_shift
BRCA1	OV	any nonsense mutation	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	27617661; 27908594	Ring finger proteins	nonsense
BRCA2	OV	CNL	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	27908594	Fanconi anemia, complementation groups	NOS
BRCA2	OV	CNL	Sensitive	SageDB	PARP inhibitors	PARP inhibitor	Preclinical	22392482	Fanconi anemia, complementation groups	NOS
BRCA2	OV	D3095E	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	E2663V	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	G2748D	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	I2627F	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	L2653P	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	R2336H	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	R2502C	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	R2659K	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	T2722R	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	W2626C	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	17924331; 27617661; 27908594	Ring finger proteins	missense
BRCA2	OV	any frameshift mutation	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	27617661; 27908594	Ring finger proteins	frame_shift
BRCA2	OV	any nonsense mutation	Sensitive		PARP inhibitors	PARP inhibitor	FDA Approved	27617661; 27908594	Fanconi anemia, complementation groups	nonsense
BRD4	HNSC	any	Sensitive	SageDB	BET inhibitors	BET inhibitor	Preclinical	20871596	GO Protein Kinase	Fusion
BTK	CLL	p.C481S	Resistant	SageDB	ibrutinib	BTK inhibitor	Clinical Trials	24869598	SH2 domain containing	missense
BTK	DLBC	481	Resistant	SageDB	ibrutinib	BTK inhibitor	Case Reports	25082755	SH2 domain containing	missense
CBL	MPD	p.C384R	Sensitive	SageDB	JAK inhibitors, dasatinib	JAK kinase inhibitor,KIT inhibitor	Preclinical	23696637	Ring finger proteins	missense
CBL	MPD	p.Y371H	Sensitive	SageDB	JAK inhibitors, dasatinib	JAK kinase inhibitor,KIT inhibitor	Preclinical	23696637	Ring finger proteins	missense
CCND1	---	CNA	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Preclinical	22471707	Cyclins	NOS
CCND1	SKCM	CNA	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Case Reports	ASCO 2014 (abstr 2528^)	Cyclins	NOS
CCND2	---	CNA	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Preclinical	22471707	Cyclins	NOS
CCND3	---	CNA	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Preclinical	22471707	Cyclins	NOS
CCNE1	---	CNA	Sensitive	SageDB	CDK2 inhibitors	CDK inhibitor	Preclinical	22471707	Cyclins	NOS
CD274	---	CNA	Sensitive	SageDB	PDL1 inhibitors	PD-1/PD-L1 inhibitor	Preclinical	25079317	V-set domain containing	NOS
CD274	BLCA	Expression	Sensitive	MyCancerGenome	PD-L1 inhibitor	PD-1/PD-L1 inhibitor	FDA Approved	25428503	V-set domain containing	NOS
CD274	NSCLC	Expression	Sensitive	MyCancerGenome	PD-L1 inhibitor	PD-1/PD-L1 inhibitor	FDA Approved	26712084	V-set domain containing	NOS
CD274	SKCM	Expression	Sensitive	MyCancerGenome	nivolumab	PD-1/PD-L1 inhibitor	Clinical Trials	24145345	V-set domain containing	NOS
CD30	HL	Expression	Sensitive	MyCancerGenome	Brentuximab Vedotin	CD30 antibody-drug conjugate	FDA Approved	21047225	Unspecified	NOS
CD74-ROS1	---	any	Sensitive	PCT	crizotinib	c-Met inhibitor	Preclinical	23486013	Unspecified	Fusion
CDK4	---	p.R24C	Sensitive	PCT	flavopiridol	CDK inhibitor	Preclinical	23486013	Cyclin-dependent kinases	missense
CDK4	SARC	CNA	Sensitive	SageDB	CDK4 inhibitors (tumors with RB expression)	CDK inhibitor	Clinical Trials	23569312	Cyclin-dependent kinases	NOS
CDK5RAP2-PDGFRA	CML	any	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	16845659	Unspecified	Fusion
CDK6	---	CNA	Sensitive	SageDB	CDK6 inhibitors	CDK inhibitor	Preclinical	22471707	Cyclin-dependent kinases	NOS
CDKN2A	BRCA	CNL	Sensitive	PCT	Palbociclib, CDK4/6 inhibitor	CDK inhibitor	Case Reports	26715889	Unspecified	NOS
CDKN2A	GBM	CNL	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Preclinical	22586120, 22711607	Unspecified	NOS
CDKN2A	SARC	CNL	Sensitive	PCT	LY2835219, CDK4/6 inhibitor	CDK inhibitor	Preclinical	25852058	Unspecified	NOS
CDKN2A	SKCM	CNL	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Case Reports	ASCO 2013 (abstr 2500)	Unspecified	NOS
CDKN2B	GBM	CNL	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Preclinical	22711607	Unspecified	NOS
CDKN2C	GBM	CNL	Sensitive	SageDB	CDK4/6 inhibitors	CDK inhibitor	Preclinical	22711607	Ankyrin repeat domain containing	NOS
CLTC-ALK	DLBC	any	Sensitive	PCT	Crizotinib	c-Met inhibitor	Preclinical	26221234	Unspecified	Fusion
COL1A1-PDGFRB	SARC	any	Sensitive	SageDB	imatinib	KIT inhibitor	FDA Approved	20194851	Unspecified	Fusion
CRKL	LUAD	Expression	Resistant	SageDB	EGFR TKIs	EGFR inhibitor (1st or 2nd gen)	Preclinical	22586683	SH2 domain containing	NOS
CRLF2	ALL	any	Sensitive	SageDB	mTOR inhibitors	mTOR inhibitor	Preclinical	22955920	Pseudoautosomal region 1	Fusion
CSF1R	MPD	p.Y571D	Sensitive	SageDB	imatinib	KIT inhibitor	Preclinical	18971950	Receptor Tyrosine Kinases	missense
CSF3R	CML	p.D771fs	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	23656643	Fibronectin type III domain containing	frame_shift_del_unspecified
CSF3R	CML	p.Q741X	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	23656643	Fibronectin type III domain containing	missense
CSF3R	CML	p.S783fs	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	23656643	Fibronectin type III domain containing	frame_shift_del_unspecified
CSF3R	CML	p.T615A	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Preclinical	23656643	Fibronectin type III domain containing	missense
CSF3R	CML	p.T618I	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Case Reports	23656643	Fibronectin type III domain containing	missense
CSF3R	CML	p.W791X	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	23656643	Fibronectin type III domain containing	missense
CSF3R	CML	p.Y752X	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	23656643	Fibronectin type III domain containing	missense
CTNNB1	COADREAD	p.R582Q	Resistant	CancerDR	FH535	Wnt inhibitor	Preclinical	23486013	Armadillo repeat containing	missense
CTNNB1	UCEC	p.D32V	Sensitive	SageDB	everolimus + letrozole	mTOR inhibitor + anti-estrogen	Clinical Trials	25624430	Armadillo repeat containing	missense
CTNNB1	UCEC	p.H36Y	Sensitive	SageDB	everolimus + letrozole	mTOR inhibitor + anti-estrogen	Clinical Trials	25624430	Armadillo repeat containing	missense
CTNNB1	UCEC	p.S37C	Sensitive	SageDB	everolimus + letrozole	mTOR inhibitor + anti-estrogen	Clinical Trials	25624430	Armadillo repeat containing	missense
CTNNB1	UCEC	p.S37Y	Sensitive	SageDB	everolimus + letrozole	mTOR inhibitor + anti-estrogen	Clinical Trials	25624430	Armadillo repeat containing	missense
DDR2	LUSC	p.G253C	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22328973	Receptor Tyrosine Kinases	missense
DDR2	LUSC	p.G505S	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22328973	Receptor Tyrosine Kinases	missense
DDR2	LUSC	p.G774V	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22328973	Receptor Tyrosine Kinases	missense
DDR2	LUSC	p.I638F	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22328973	Receptor Tyrosine Kinases	missense
DDR2	LUSC	p.L239R	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22328973	Receptor Tyrosine Kinases	missense
DDR2	LUSC	p.L63V	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	22328973	Receptor Tyrosine Kinases	missense
DDR2	LUSC	p.S768R	Sensitive	SageDB	dasatinib + erlotinib	KIT inhibitor + EGFR inhibitor (1st or 2nd gen)	Case Reports	22328973	Receptor Tyrosine Kinases	missense
DLL3	NEC	Expression	Sensitive	MyCancerGenome	DLL3 antibody-drug conjugate	DLL3 antibody-drug conjugate	Preclinical	26311731	Unspecified	NOS
EGFR	COADREAD	CNA	Sensitive	SageDB	anti-EGFR mAbs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	18794099, 17664472	Receptor Tyrosine Kinases	NOS
EGFR	COADREAD	p.G465R	Resistant	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Preclinical	25623215	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.I491M	Resistant	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Preclinical	25623215	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.K467T	Sensitive	SageDB	panitumumab	EGFR inhibitor (1st or 2nd gen)	Preclinical	25623215	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.K467T	Resistant	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Case Reports	25623215	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.R451C	Resistant	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Case Reports	25623215	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.S464L	Resistant	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Preclinical	25623215	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.S492R	Sensitive	SageDB	novel anti-EGFR mAbs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	25962717	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.S492R	Resistant	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Case Reports	22270724	Receptor Tyrosine Kinases	missense
EGFR	COADREAD	p.Y1069C	Sensitive	CancerDR	Lapatinib	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EGFR	DLBC	p.K209N	Sensitive	CancerDR	Lapatinib	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EGFR	GBM	Expression	Resistant	SageDB	EGFR TKIs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	16282176, 16278407	Receptor Tyrosine Kinases	NOS
EGFR	GBM	exon p.30-336 	Resistant	SageDB	EGFR TKIs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	19204207	Receptor Tyrosine Kinases	in_frame_del
EGFR	GBM	p.A289V	Sensitive	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Preclinical	17177598	Receptor Tyrosine Kinases	missense
EGFR	GBM	p.G598V	Sensitive	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Preclinical	17177598	Receptor Tyrosine Kinases	missense
EGFR	GBM	p.R108K	Sensitive	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Preclinical	17177598	Receptor Tyrosine Kinases	missense
EGFR	GBM	p.T263P	Sensitive	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Preclinical	17177598	Receptor Tyrosine Kinases	missense
EGFR	HNSC	Expression	Resistant	SageDB	gefitinib	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	21274259, 22261807	Receptor Tyrosine Kinases	NOS
EGFR	HNSC	p.P546S	Sensitive	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Case Reports	23578570	Receptor Tyrosine Kinases	missense
EGFR	HNSC	p.P753S	Sensitive	SageDB	cetuximab + sirolimus	EGFR inhibitor (1st or 2nd gen)+ mTOR inhibitor	Case Reports	24934779	Receptor Tyrosine Kinases	missense
EGFR	HNSC	p.V843I	Resistant	SageDB	gefitinib	EGFR inhibitor (1st or 2nd gen)	Case Reports	21274259	Receptor Tyrosine Kinases	missense
EGFR	LAML	p.R98Q	Resistant	CancerDR	Lapatinib	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EGFR	LAML	p.T751I	Resistant	CancerDR	Lapatinib	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EGFR	LAML	p.W1157C	Resistant	CancerDR	Lapatinib	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EGFR	LUAD	exon p.750-756 	Sensitive	PCT	Afatinib	HER-2 inhibitor	FDA Approved	23816960	Receptor Tyrosine Kinases	in_frame_del
EGFR	NSCLC	719	Sensitive	MyCancerGenome	afatinib	HER-2 inhibitor	Clinical Trials	26051236	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	CNA	Resistant	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	ASCO 2015 (abstr e19028)	Receptor Tyrosine Kinases	NOS
EGFR	NSCLC	any	Sensitive		erlotinib	EGFR inhibitor (1st or 2nd gen)	Case Reports	27102076	Receptor Tyrosine Kinases	Fusion
EGFR	NSCLC	exon c.2186-2283 	Sensitive	MyCancerGenome	gefitinib	EGFR inhibitor (1st or 2nd gen)	FDA Approved	21670455	Receptor Tyrosine Kinases	in_frame_ins
EGFR	NSCLC	exon c.2284-2469 	Resistant	MyCancerGenome	gefitinib	EGFR inhibitor (1st or 2nd gen)	FDA Approved	26096453	Receptor Tyrosine Kinases	in_frame_ins
EGFR	NSCLC	exon p.729-761 	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	in_frame_del
EGFR	NSCLC	exon p.762-775 	Resistant	PCT	Erlotinib, gefitinib	EGFR inhibitor (1st or 2nd gen)	Case Reports	21764376	Receptor Tyrosine Kinases	in_frame_ins
EGFR	NSCLC	exon p.762-823 	Sensitive	SageDB	HSP90 inhibitors	Hsp90 inhibitor	Clinical Trials	ASCO 2014 (abstr 8015)	Receptor Tyrosine Kinases	in_frame_ins
EGFR	NSCLC	exon p.762-823 	Resistant	SageDB	first-generation and irreversible EGFR TKIs	EGFR inhibitor (1st,2nd, or 3rd gen)	Clinical Trials	21764376, 21764376	Receptor Tyrosine Kinases	in_frame_ins
EGFR	NSCLC	exon p.763-764 	Sensitive	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Case Reports	23969006	Receptor Tyrosine Kinases	in_frame_ins
EGFR	NSCLC	p.C797S	Resistant	SageDB	irreversible EGFR T790M inhibitors	EGFR inhibitor (3rd gen)	Clinical Trials	25939061	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.ELR746in_frame_del	Sensitive	CancerDR	ZD6474	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	in_frame_del
EGFR	NSCLC	p.ELREA746in_frame_del	Sensitive	CancerDR	ZD6474	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	in_frame_del
EGFR	NSCLC	p.G719A	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.G719C	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.G719D	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.G719S	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.L747S	Resistant	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	Preclinical	28424065	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.L747S	Sensitive	SageDB	osimertinib	EGFR inhibitor (3rd gen)	Preclinical	28424065	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.L858R	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.L861P	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.L861Q	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.L861R	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.S768I	Sensitive	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.T790M	Sensitive	MyCancerGenome	AZD9291	EGFR TKI (3rd gen)	FDA Approved	25923549	Receptor Tyrosine Kinases	missense
EGFR	NSCLC	p.T790M	Resistant	SageDB	erlotinib, afatinib	EGFR inhibitor (1st or 2nd gen),HER-2 inhibitor	FDA Approved	18458038	Receptor Tyrosine Kinases	missense
EGFR	SKCM	p.V1011M	Sensitive	CancerDR	Gefitinib	EGFR inhibitor (1st or 2nd gen)	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EGFR	UCEC	p.E690K	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Case Reports	22885469	Receptor Tyrosine Kinases	missense
EGFR	UCEC	p.R973Q	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
EML1-ABL1	CML	any	Sensitive	PCT	imatinib	KIT inhibitor	Case Reports	15713800	Unspecified	Fusion
EML4-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
EPHA2	---	Expression	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	18047674, 19010823, 19861960	Sterile alpha motif (SAM) domain containing	NOS
EPHA2	LUSC	p.G391R	Sensitive	SageDB	mTOR inhibitors, dasatinib	mTOR inhibitor, KIT inhibitor	Preclinical	20360610	Sterile alpha motif (SAM) domain containing	missense
EPHA3	---	Expression	Sensitive	SageDB	EPHA3 inhibitors	EphA3 inhibitor	Preclinical	25125683	Sterile alpha motif (SAM) domain containing	NOS
ERBB2	---	p.C311R	Sensitive	SageDB	ERBB2 TKIs, trastuzumab	HER-2 inhibitor	Preclinical	22908275	Receptor Tyrosine Kinases	missense
ERBB2	---	p.C334S	Sensitive	SageDB	ERBB2 TKIs	HER-2 inhibitor	Preclinical	22908275	Receptor Tyrosine Kinases	missense
ERBB2	---	p.E321G	Sensitive	SageDB	ERBB2 TKIs	HER-2 inhibitor	Preclinical	22908275	Receptor Tyrosine Kinases	missense
ERBB2	---	p.G309E	Sensitive	SageDB	ERBB2 TKIs, trastuzumab	HER-2 inhibitor	Preclinical	22908275	Receptor Tyrosine Kinases	missense
ERBB2	---	p.S310F	Sensitive	SageDB	ERBB2 TKIs, trastuzumab	HER-2 inhibitor	Preclinical	22908275	Receptor Tyrosine Kinases	missense
ERBB2	---	p.S310Y	Sensitive	SageDB	ERBB2 TKIs, trastuzumab	HER-2 inhibitor	Preclinical	22908275	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	CNA	Sensitive	SageDB	trastuzumab, lapatinib, pertuzumab, ado-trastuzumab emtansine	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	FDA Approved	17208639	Receptor Tyrosine Kinases	NOS
ERBB2	BRCA	Expression	Sensitive	MyCancerGenome	trastuzumab	HER-2 inhibitor	FDA Approved	10561337	Receptor Tyrosine Kinases	NOS
ERBB2	BRCA	p.D769H	Sensitive	SageDB	trastuzumab, lapatinib, neratinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.D769Y	Sensitive	SageDB	trastuzumab, lapatinib, neratinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.G309A	Sensitive	SageDB	lapatinib, neratinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.L755S	Sensitive	SageDB	neratinib	HER-2 inhibitor	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.R896C	Sensitive	SageDB	trastuzumab, lapatinib, neratinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.V659E	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Case Reports	23950206	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.V777L	Sensitive	SageDB	lapatinib, neratinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	BRCA	p.V842I	Sensitive	SageDB	lapatinib, neratinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	23220880	Receptor Tyrosine Kinases	missense
ERBB2	COADREAD	CNA	Sensitive	SageDB	trastuzumab + lapatinib (in KRAS wt)	HER-2 inhibitor + EGFR inhibitor (1st or 2nd gen)	Clinical Trials	ASCO 2015 (abstr 3508)	Receptor Tyrosine Kinases	NOS
ERBB2	COADREAD	CNA	Resistant	SageDB	anti-EGFR mAbs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	22586653, 23348520	Receptor Tyrosine Kinases	NOS
ERBB2	COADREAD	p.L720P	Sensitive	CancerDR	Lapatinib	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
ERBB2	HNSC	CNA	Sensitive	SageDB	trastuzumab-based chemotherapy	HER-2 inhibitor	Case Reports	21380780	Receptor Tyrosine Kinases	NOS
ERBB2	LUAD	exon p.775-881 	Sensitive	SageDB	trastuzumab-based therapy	HER-2 inhibitor	Clinical Trials	ASCO 2015 (abstr 11076)	Receptor Tyrosine Kinases	in_frame_ins
ERBB2	LUAD	p.G776L	Sensitive	SageDB	trastuzumab-based therapy	HER-2 inhibitor	Case Reports	16775247	Receptor Tyrosine Kinases	missense
ERBB2	LUAD	p.V659E	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Case Reports	23950206	Receptor Tyrosine Kinases	missense
ERBB2	NSCLC	exon c.2308-2493 	Sensitive	MyCancerGenome	trastuzumab	HER-2 inhibitor	Clinical Trials	23610105	Receptor Tyrosine Kinases	in_frame_ins
ERBB2	NSCLC	p.A859T	Sensitive	PCT	Trastuzumab	HER-2 inhibitor	Case Reports	16775247	Receptor Tyrosine Kinases	missense
ERBB2	OV	CNA	Sensitive	SageDB	trastuzumab	HER-2 inhibitor	Clinical Trials	20003286, 12525520	Receptor Tyrosine Kinases	NOS
ERBB2	OV	p.V842I	Sensitive	CancerDR	BIBW2992	HER-2 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
ERBB2	STAD	CNA	Sensitive	SageDB	trastuzumab	HER-2 inhibitor	FDA Approved	20728210	Receptor Tyrosine Kinases	NOS
ERBB2	STAD	Expression	Sensitive	SageDB	trastuzumab	HER-2 inhibitor	FDA Approved	20728210	Receptor Tyrosine Kinases	NOS
ERBB2	UCEC	CNA	Sensitive	SageDB	trastuzumab + lapatinib	HER-2 inhibitor + EGFR inhibitor (1st or 2nd gen)	Preclinical	25294905	Receptor Tyrosine Kinases	NOS
ERBB2	UCEC	CNA	Resistant	SageDB	trastuzumab alone	HER-2 inhibitor	Clinical Trials	19840887	Receptor Tyrosine Kinases	NOS
ERBB3	---	p.G284R	Sensitive	SageDB	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen), PI3K inhibitor + MEK inhibitor	Preclinical	23680147	Receptor Tyrosine Kinases	missense
ERBB3	---	p.P262H	Sensitive	SageDB	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen), PI3K inhibitor + MEK inhibitor	Preclinical	23680147	Receptor Tyrosine Kinases	missense
ERBB3	---	p.Q809R	Sensitive	SageDB	trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen), PI3K inhibitor + MEK inhibitor	Preclinical	23680147	Receptor Tyrosine Kinases	missense
ERBB3	BLCA	p.G284R	Sensitive	SageDB	afatinib	HER-2 inhibitor	Case Reports	ASCO 2015 (abstr e15516)	Receptor Tyrosine Kinases	missense
ERBB3	BLCA	p.R103G	Sensitive	SageDB	afatinib	HER-2 inhibitor	Case Reports	ASCO 2015 (abstr e15516)	Receptor Tyrosine Kinases	missense
ERBB4	LUAD	any	Sensitive	SageDB	lapatinib, afatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	24727320	Receptor Tyrosine Kinases	Fusion
ERBB4	SKCM	p.E317K	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	19718025	Receptor Tyrosine Kinases	missense
ERBB4	SKCM	p.E452K	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	19718025	Receptor Tyrosine Kinases	missense
ERBB4	SKCM	p.E542K	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	19718025	Receptor Tyrosine Kinases	missense
ERBB4	SKCM	p.E872K	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	19718025	Receptor Tyrosine Kinases	missense
ERBB4	SKCM	p.R393W	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	19718025	Receptor Tyrosine Kinases	missense
ERBB4	SKCM	p.R544W	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	19718025	Receptor Tyrosine Kinases	missense
ERCC1	NSCLC	Underexpression	Sensitive	SageDB	cisplatin	Antineoplastic	Preclinical	23275151, 23934192	Unspecified	NOS
ESR1	BRCA	536	Resistant	SageDB	anti-estrogens	anti-estrogen	Clinical Trials	24185512, 24185510	Nuclear hormone receptors	missense
ESR1	BRCA	537	Sensitive	SageDB	novel estrogen receptor degrader	anti-estrogen	Clinical Trials	AACR 2015 (abstr CT231)	Nuclear hormone receptors	missense
ESR1	BRCA	537	Resistant	SageDB	anti-estrogens	anti-estrogen	Clinical Trials	24185512, 24185510, 24398047	Nuclear hormone receptors	missense
ESR1	BRCA	538	Sensitive	SageDB	novel estrogen receptor degrader	anti-estrogen	Clinical Trials	AACR 2015 (abstr CT231)	Nuclear hormone receptors	missense
ESR1	BRCA	538	Resistant	SageDB	anti-estrogens	anti-estrogen	Clinical Trials	24185512, 24185510, 24398047	Nuclear hormone receptors	missense
ESR1	BRCA	Expression	Sensitive	MyCancerGenome	aromatase inhibitors	anti-estrogen	FDA Approved	10334533	Nuclear hormone receptors	NOS
ESR1	BRCA	any	Resistant	SageDB	anti-estrogens	anti-estrogen	Preclinical	24055055	Nuclear hormone receptors	Fusion
ESR1	BRCA	p.E380Q	Resistant	SageDB	anti-estrogens	anti-estrogen	Clinical Trials	24185512, 24185510, 24398047	Nuclear hormone receptors	missense
ESR1	BRCA	p.P535H	Resistant	SageDB	anti-estrogens	anti-estrogen	Clinical Trials	24185512	Nuclear hormone receptors	missense
ETS	PRAD	any	Sensitive		PARP inhibitors	PARP inhibitor	Preclinical	21575865	Unspecified	Fusion
ETV6-ABL1	MPD	any	Sensitive	PCT	nilotinib	KIT inhibitor	Case Reports	24053143	Unspecified	Fusion
ETV6-ABL1	MPD	any	Resistant	PCT	imatinib	KIT inhibitor	Case Reports	24053143	Unspecified	Fusion
EWS	SARC	any	Sensitive		PARP inhibitors	PARP inhibitor	Preclinical	22287547	Unspecified	Fusion
EZH2	DLBC	641	Sensitive	SageDB	EZH2 inhibitor	EZH2 inhibitor	Preclinical	23023262	SANT/Myb domain containing	missense
EZH2	DLBC	677	Sensitive	SageDB	EZH2 inhibitor	EZH2 inhibitor	Preclinical	23023262	SANT/Myb domain containing	missense
EZH2	DLBC	p.Y646F	Sensitive	SageDB	EZH2 inhibitor	EZH2 inhibitor	Preclinical	24563539	SANT/Myb domain containing	missense
FBXW7	---	Underexpression	Resistant	SageDB	anti-tubulin agents	tubulin inhibitor	Preclinical	21368834	WD repeat domain containing	NOS
FGF3	BRCA	CNA	Sensitive	SageDB	dovitinib	FGFR inhibitor	Clinical Trials	23658459	Unspecified	NOS
FGF4	BRCA	CNA	Sensitive	SageDB	dovitinib	FGFR inhibitor	Clinical Trials	23658459	Endogenous ligands	NOS
FGFR1	BRCA	CNA	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Clinical Trials	25193991	Receptor Tyrosine Kinases	NOS
FGFR1	HNSC	CNA	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	23418312	Receptor Tyrosine Kinases	NOS
FGFR1	LUSC	CNA	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Clinical Trials	AACR 2012 (abstr LB-122), AACR 2013 (abstr LB-145)	Receptor Tyrosine Kinases	NOS
FGFR1	UCEC	p.T79A	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FGFR2	---	p.N550H	Resistant	PCT	Dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	---	p.N550K	Resistant	PCT	Dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	---	p.N550S	Resistant	PCT	Dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	BRCA	CNA	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Case Reports	25193991	Receptor Tyrosine Kinases	NOS
FGFR2	CHOL	any	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	23558953	Receptor Tyrosine Kinases	Fusion
FGFR2	HNSC	p.P253R	Sensitive	SageDB	pazopanib	FGFR inhibitor	Case Reports	23786770	Receptor Tyrosine Kinases	missense
FGFR2	LUSC	p.K660N	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	25035393	Receptor Tyrosine Kinases	missense
FGFR2	LUSC	p.S320C	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	23786770	Receptor Tyrosine Kinases	missense
FGFR2	LUSC	p.W290C	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	23786770	Receptor Tyrosine Kinases	missense
FGFR2	NSCLC	p.K660N	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	25035393	Receptor Tyrosine Kinases	missense
FGFR2	STAD	CNA	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Clinical Trials	ASCO 2015 (abstr 2508)	Receptor Tyrosine Kinases	NOS
FGFR2	UCEC	550	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	550	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.E566G	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.E566G	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.I548V	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.I548V	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.K660E	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.K660E	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.L618M	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.L618M	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.M536I	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.M536I	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.M538I	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.M538I	Resistant	SageDB	dovitinib	FGFR inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.N549K	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	18552176, 22238366, 23002168	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.S252W	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	18552176, 22238366, 23002168	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.V565I	Sensitive	SageDB	selective FGFR inhibitor	FGFR inhibitor	Preclinical	ENA 2014 (abstr 381)	Receptor Tyrosine Kinases	missense
FGFR2	UCEC	p.V565I	Resistant	SageDB	ponatinib	KIT inhibitor	Preclinical	23908597	Receptor Tyrosine Kinases	missense
FGFR3	BLCA	any	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Case Reports	AACR 2014 (abstr CT325)	Receptor Tyrosine Kinases	Fusion
FGFR3	BLCA	p.S773F	Sensitive	CancerDR	PD173074	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FGFR3	GBM	any	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Clinical Trials	ASCO 2014 (abstr 2501)	Receptor Tyrosine Kinases	Fusion
FGFR3	MM	650	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	16091734, 20439987	Receptor Tyrosine Kinases	missense
FGFR3	MM	p.V555M	Resistant	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	22869148	Receptor Tyrosine Kinases	missense
FGFR3	MM	p.Y373C	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	22869148	Receptor Tyrosine Kinases	missense
FGFR3	MM	p.Y373C	Resistant	SageDB	bortezomib	Proteasome inhibitor	Preclinical	19331127, 21273588	Receptor Tyrosine Kinases	missense
FGFR4	SARC	535	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	19809159, 24124571	Receptor Tyrosine Kinases	missense
FGFR4	SARC	550	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	19809159, 24124571	Receptor Tyrosine Kinases	missense
FIP1L1-PDGFRA	MPD	any	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	FDA Approved	12660384	Unspecified	Fusion
FLT1	LAML	p.S1277N	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FLT3	DLBC	p.V592A	Sensitive	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FLT3	LAML	676	Sensitive	SageDB	crenolanib, PKC412	FLT3 inhibitor	Preclinical	24619500	Receptor Tyrosine Kinases	missense
FLT3	LAML	676	Resistant	SageDB	quizartinib	FLT3 inhibitor	Preclinical	23878140	Receptor Tyrosine Kinases	missense
FLT3	LAML	691	Sensitive	SageDB	novel FLT3 inhibitors	FLT3 inhibitor	Preclinical	25847190	Receptor Tyrosine Kinases	missense
FLT3	LAML	691	Resistant	SageDB	quizartinib	FLT3 inhibitor	Preclinical	22504184	Receptor Tyrosine Kinases	missense
FLT3	LAML	835	Sensitive	SageDB	lestaurtinib	FLT3 inhibitor	Case Reports	16857985	Receptor Tyrosine Kinases	missense
FLT3	LAML	835	Resistant	SageDB	sorafenib	Angiogenesis inhibitor	Case Reports	22368270	Receptor Tyrosine Kinases	missense
FLT3	LAML	842	Sensitive	SageDB	crenolanib, PKC412	FLT3 inhibitor	Preclinical	24619500	Receptor Tyrosine Kinases	missense
FLT3	LAML	842	Resistant	SageDB	ponatinib	KIT inhibitor	Preclinical	23430109	Receptor Tyrosine Kinases	missense
FLT3	LAML	p.V592A	Sensitive	CancerDR	Sunitinib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FLT3	NSCLC	p.P937H	Sensitive	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FLT3	NSCLC	p.Q910*	Resistant	CancerDR	CEP701	FLT3 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	nonsense
FLT3	UCEC	p.R311W	Sensitive	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
FRS2	SARC	CNA	Sensitive	SageDB	FGFR inhibitors	FGFR inhibitor	Preclinical	23393200	Unspecified	NOS
GNA11	SKCM	p.Q209L	Sensitive	SageDB	selumetinib	MEK inhibitor	Clinical Trials	ASCO 2013 (abstr CRA9003)	Unspecified	missense
GNA11	SKCM	p.Q209P	Sensitive	SageDB	selumetinib	MEK inhibitor	Clinical Trials	ASCO 2013 (abstr CRA9003)	Unspecified	missense
GNAQ	SKCM	209	Sensitive	SageDB	selumetinib	MEK inhibitor	Clinical Trials	ASCO 2013 (abstr CRA9003)	Unspecified	missense
GNAS	---	201	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	21835143	Granins	missense
HDAC2	LAML	p.P5S	Resistant	CancerDR	MS275	HDAC inhibitor	Preclinical	23486013	Unspecified	missense
HDAC3	LAML	p.P23R	Resistant	CancerDR	Vorinostat	HDAC inhibitor	Preclinical	23486013	Unspecified	missense
HDAC8	PRAD	p.R223fs	Resistant	CancerDR	Vorinostat	HDAC inhibitor	Preclinical	23486013	X-linked mental retardation	frame_shift_del_unspecified
HGF	BRCA	CNA	Resistant	SageDB	trastuzumab in HER2-ampl	HER-2 inhibitor	Clinical Trials	22850551	Unspecified	NOS
HRAS	CESC	12	Sensitive	SageDB	mTOR inhibitors	mTOR inhibitor	Preclinical	22345164	RAS type family GTPases	missense
HSP90AA1	NSCLC	p.R467Q	Resistant	CancerDR	AUY922	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	missense
HSP90AB1	LIHC	p.V575A	Resistant	CancerDR	17AAG	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	missense
HSP90AB4P	LAML	p.I354in_frame_del	Resistant	CancerDR	17AAG	Hsp90 inhibitor	Preclinical	23486013	Unspecified	in_frame_del
HSP90B1	BLCA	p.E791in_frame_del	Resistant	CancerDR	17AAG	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	in_frame_del
HSP90B1	COADREAD	p.E791in_frame_del	Resistant	CancerDR	AUY922	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	in_frame_del
HSP90B1	LAML	p.E791in_frame_del	Resistant	CancerDR	17AAG	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	in_frame_del
HSP90B1	LIHC	p.E791in_frame_del	Resistant	CancerDR	17AAG	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	in_frame_del
HSP90B1	NSCLC	p.E758Q	Resistant	CancerDR	17AAG	Hsp90 inhibitor	Preclinical	23486013	Heat shock 90kDa proteins	missense
HSP90B3P	COADREAD	p.K348fs	Resistant	CancerDR	AUY922	Hsp90 inhibitor	Preclinical	23486013	Unspecified	frame_shift_del_unspecified
IDH1	GBM	p.R132H	Sensitive	SageDB	IDH1 inhibitor	IDH inhibitor	Preclinical	23558169	Unspecified	missense
IDH2	LAML	p.R140Q	Sensitive	SageDB	IDH2 inhibitor	IDH inhibitor	Clinical Trials	AACR 2014 (abstr CT103)	Unspecified	missense
IDH2	LAML	p.R172K	Sensitive	SageDB	IDH2 inhibitor	IDH inhibitor	Clinical Trials	AACR 2014 (abstr CT103)	Unspecified	missense
IGF1R	COADREAD	p.A828T	Sensitive	CancerDR	AEW541	IGF-1R inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
IGF1R	LAML	p.D1146N	Sensitive	CancerDR	AEW541	IGF-1R inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
IGF1R	LUAD	Expression	Resistant	SageDB	erlotinib	EGFR inhibitor (1st or 2nd gen)	Preclinical	24458568	Receptor Tyrosine Kinases	NOS
IGF1R	MPNST	p.L360F	Sensitive	CancerDR	OSI906	IGF-1R inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
IL2RA	CTCL	Expression	Sensitive	MyCancerGenome	denileukin diftitox	CD25 antibody-drug conjugate	FDA Approved	20212249	Interleukin receptors	NOS
INI1	SARC	CNL	Sensitive	SageDB	EZH2 inhibitor	EZH2 inhibitor	Case Reports	ENA 2014 (abstr 6LBA)	Unspecified	NOS
JAK1	ALL	p.S646F	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Preclinical	22955920	TK	missense
JAK2	ALL	683	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Preclinical	18805579, 22955920	SH2 domain containing	missense
JAK2	ALL	any	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Preclinical	22875628, 22899477	SH2 domain containing	Fusion
JAK2	LAML	p.V617F	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	Clinical Trials	22422826	SH2 domain containing	missense
JAK2	MPD	p.V617F	Sensitive	SageDB	ruxolitinib	JAK kinase inhibitor	FDA Approved	26975727	SH2 domain containing	missense
JAK3	DLBC	p.A572V	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	22705984	TK	missense
JAK3	DLBC	p.A573V	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	22705984	TK	missense
JAK3	LAML	p.I87T	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	18397343	TK	missense
JAK3	LAML	p.Q501H	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	18397343	TK	missense
JAK3	LAML	p.R657Q	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	18397343	TK	missense
KDR	---	p.A1065T	Sensitive	SageDB	VEGFR inhibitors	Angiogenesis inhibitor	Preclinical	24569783	V-set domain containing	missense
KDR	COADREAD	p.G424D	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	COADREAD	p.H1213Q	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	COADREAD	p.I915T	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	LAML	p.E685G	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	NSCLC	p.D392N	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	NSCLC	p.G1145R	Sensitive	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	NSCLC	p.G255R	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	NSCLC	p.Q2R	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	V-set domain containing	missense
KDR	NSCLC	p.R791Q	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	V-set domain containing	missense
KIF5B-RET	LUAD	any	Sensitive	PCT	cabozantinib	Angiogenesis inhibitor	Case Reports	23533264	Unspecified	Fusion
KIT	COADREAD	p.M882V	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
KIT	GIST	670	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	816	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	822	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	Expression	Sensitive	MyCancerGenome	imatinib	KIT inhibitor	FDA Approved	18235121	Receptor Tyrosine Kinases	NOS
KIT	GIST	Wild Type	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Clinical Trials	18955458	Receptor Tyrosine Kinases	NOS
KIT	GIST	Wild Type	Resistant	SageDB	imatinib	KIT inhibitor	Clinical Trials	14645423	Receptor Tyrosine Kinases	NOS
KIT	GIST	exon p.449-514	Sensitive	SageDB	imatinib, sunitinib, regorafenib	KIT inhibitor,Angiogenesis inhibitor	FDA Approved	16624552; 14645423	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.449-514	Resistant	SageDB	imatinib (low dose)	KIT inhibitor	Clinical Trials	18955458, 18955451, 16624552	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.450-513	Sensitive	MyCancerGenome	sunitinib	Angiogenesis inhibitor	Clinical Trials	18955458; 21104107	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.550-591	Sensitive	MyCancerGenome	imatinib	KIT inhibitor	FDA Approved	18955451; FDA approved for KIT-mutated GIST	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.550-591 	Sensitive	MyCancerGenome	imatinib	KIT inhibitor	FDA Approved	16624552; FDA approved for KIT-mutated GIST	Receptor Tyrosine Kinases	in_frame_del
KIT	GIST	exon p.550-592	Sensitive	SageDB	imatinib, sunitinib, regorafenib	KIT inhibitor,Angiogenesis inhibitor	FDA Approved	18955451; FDA approved for KIT-mutated GIST	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.627-663	Sensitive	MyCancerGenome	sunitinib	Angiogenesis inhibitor	Case Reports	18955451	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.627-664	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Clinical Trials	18955458	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.664-714	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Clinical Trials	18955458	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.788-828	Resistant	SageDB	imatinib, sunitinib	KIT inhibitor,Angiogenesis inhibitor	Preclinical	23840364	Receptor Tyrosine Kinases	missense
KIT	GIST	exon p.829-860	Sensitive	SageDB	ponatinib	KIT inhibitor	Clinical Trials	ASCO 2015 (abstr 10517)	Receptor Tyrosine Kinases	missense
KIT	GIST	p.502in_frame_insSA	Sensitive	MyCancerGenome	sunitinib	Angiogenesis inhibitor	Clinical Trials	18955458; 21104107	Receptor Tyrosine Kinases	in_frame_ins
KIT	GIST	p.A829P	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	25239608	Receptor Tyrosine Kinases	missense
KIT	GIST	p.A829P	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	p.D419in_frame_del	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	23599150	Receptor Tyrosine Kinases	in_frame_del
KIT	GIST	p.H687Y	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	p.K642E	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Clinical Trials	16954519	Receptor Tyrosine Kinases	missense
KIT	GIST	p.N655K	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	25239608	Receptor Tyrosine Kinases	missense
KIT	GIST	p.T670I	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	25239608	Receptor Tyrosine Kinases	missense
KIT	GIST	p.T670I	Resistant	SageDB	imatinib	KIT inhibitor	Case Reports	24687822	Receptor Tyrosine Kinases	missense
KIT	GIST	p.V559I	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	p.V654A	Sensitive	SageDB	ponatinib	KIT inhibitor	Preclinical	25239608	Receptor Tyrosine Kinases	missense
KIT	GIST	p.V654A	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	GIST	p.Y823D	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	23582185, 21689725, 17259998	Receptor Tyrosine Kinases	missense
KIT	LAML	p.D816V	Sensitive	SageDB	dasatinib	KIT inhibitor	Case Reports	18986703	Receptor Tyrosine Kinases	missense
KIT	LAML	p.L160W	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
KIT	LAML	p.N822K	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	23149070	Receptor Tyrosine Kinases	missense
KIT	LAML	p.N822K	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
KIT	MPD	p.D52N	Sensitive	PCT	SCF	KIT inhibitor	Case Reports	9168438	Receptor Tyrosine Kinases	missense
KIT	MPD	p.K509I	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	16183119	Receptor Tyrosine Kinases	missense
KIT	SKCM	CNA	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Clinical Trials	22261812	Receptor Tyrosine Kinases	NOS
KIT	SKCM	CNA	Resistant	SageDB	imatinib	KIT inhibitor	Clinical Trials	23775962	Receptor Tyrosine Kinases	NOS
KIT	SKCM	exon p.550-592	Sensitive	SageDB	imatinib	KIT inhibitor	FDA Approved	23775962	Receptor Tyrosine Kinases	missense
KIT	SKCM	exon p.627-664	Sensitive	SageDB	imatinib	KIT inhibitor	FDA Approved	23775962	Receptor Tyrosine Kinases	missense
KIT	SKCM	exon p.788-828	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Case Reports	20372153	Receptor Tyrosine Kinases	missense
KIT	SKCM	exon p.788-828	Resistant	SageDB	imatinib	KIT inhibitor	Clinical Trials	21690468, 21642685	Receptor Tyrosine Kinases	missense
KIT	SKCM	exon p.829-860	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Case Reports	20372153	Receptor Tyrosine Kinases	missense
KIT	SKCM	exon p.829-860	Resistant	SageDB	imatinib	KIT inhibitor	Clinical Trials	21690468, 21642685	Receptor Tyrosine Kinases	missense
KIT	SKCM	p.D820Y	Sensitive	SageDB	nilotinib	KIT inhibitor	Case Reports	25695690	Receptor Tyrosine Kinases	missense
KIT	SKCM	p.K642E	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	18510589	Receptor Tyrosine Kinases	missense
KIT	SKCM	p.L576P	Sensitive	MyCancerGenome	KIT inhibitors	KIT inhibitor	Case Reports	19671763	Receptor Tyrosine Kinases	missense
KIT	SKCM	p.V559A	Sensitive	MyCancerGenome	KIT inhibitors	KIT inhibitor	Case Reports	19718013	Receptor Tyrosine Kinases	missense
KIT	SKCM	p.W557R	Sensitive	MyCancerGenome	KIT inhibitors	KIT inhibitor	Case Reports	19018266	Receptor Tyrosine Kinases	missense
KIT	THCA	p.V560in_frame_del	Sensitive	MyCancerGenome	sunitinib (KIT inhibitor)	Angiogenesis inhibitor, KIT inhibitor	Case Reports	15201427	Receptor Tyrosine Kinases	in_frame_del
KIT	THCA	p.Y553N	Sensitive	MyCancerGenome	imatinib (KIT inhibitor)	KIT inhibitor	Case Reports	21969494	Receptor Tyrosine Kinases	missense
KIT	THYM	p.D820E	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Case Reports	19461405	Receptor Tyrosine Kinases	missense
KIT	THYM	p.H697Y	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Preclinical	19861435	Receptor Tyrosine Kinases	missense
KIT	THYM	p.V560in_frame_del	Sensitive	SageDB	imatinib	KIT inhibitor	Case Reports	15201427	Receptor Tyrosine Kinases	in_frame_del
KIT	THYM	p.Y553N	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Case Reports	23375402	Receptor Tyrosine Kinases	missense
KLC1-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
KRAS	ALL	12	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	18701506	RAS type family GTPases	missense
KRAS	CESC	12	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	22169769	RAS type family GTPases	missense
KRAS	CESC	13	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	22169769	RAS type family GTPases	missense
KRAS	CESC	61	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	22169769	RAS type family GTPases	missense
KRAS	CHOL	12	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Clinical Trials	23391555	RAS type family GTPases	missense
KRAS	CHOL	13	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Clinical Trials	23391555	RAS type family GTPases	missense
KRAS	CHOL	61	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Clinical Trials	23391555	RAS type family GTPases	missense
KRAS	COADREAD	12	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	RAS type family GTPases	missense
KRAS	COADREAD	12	Resistant	SageDB	panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839	RAS type family GTPases	missense
KRAS	COADREAD	13	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	RAS type family GTPases	missense
KRAS	COADREAD	13	Resistant	SageDB	panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839	RAS type family GTPases	missense
KRAS	COADREAD	146	Sensitive	SageDB	MEK inhibitors + PI3K pathway inhibitors	MEK inhibitor + PI3K inhibitor	Preclinical	22392911	RAS type family GTPases	missense
KRAS	COADREAD	146	Resistant	SageDB	cetuximab, panitumumab	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739, 21163703, 23325582	RAS type family GTPases	missense
KRAS	COADREAD	61	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	RAS type family GTPases	missense
KRAS	COADREAD	61	Resistant	SageDB	panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839	RAS type family GTPases	missense
KRAS	COADREAD	CNA	Resistant	SageDB	BRAF inhibitor + MEK inhibitor/anti-EGFR mAb	B-Raf inhibitor + MEK inhibitor/EGFR inhibitor (1st or 2nd gen)	Case Reports	ENA 2014 (abstr 428)	RAS type family GTPases	NOS
KRAS	COADREAD	Wild Type	Sensitive	SageDB	panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839	RAS type family GTPases	NOS
KRAS	COADREAD	p.G13D	Sensitive	SageDB	cetuximab	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20978259; 22734028	RAS type family GTPases	missense
KRAS	COADREAD	p.K117N	Resistant	MyCancerGenome	cetuximab/panitumumab (anti-EGFR antibodies)	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	26952655	RAS type family GTPases	missense
KRAS	GIST	12	Resistant	SageDB	imatinib	KIT inhibitor	Case Reports	24687822	RAS type family GTPases	missense
KRAS	LIHC	12	Sensitive	SageDB	sorafenib + MEK inhibitor	Angiogenesis inhibitor + MEK inhibitor	Clinical Trials	25294897	RAS type family GTPases	missense
KRAS	LIHC	13	Sensitive	SageDB	sorafenib + MEK inhibitor	Angiogenesis inhibitor + MEK inhibitor	Clinical Trials	25294897	RAS type family GTPases	missense
KRAS	LIHC	61	Sensitive	SageDB	sorafenib + MEK inhibitor	Angiogenesis inhibitor + MEK inhibitor	Clinical Trials	25294897	RAS type family GTPases	missense
KRAS	MM	12	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	22985491	RAS type family GTPases	missense
KRAS	MM	13	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	22985491	RAS type family GTPases	missense
KRAS	MM	61	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	22985491	RAS type family GTPases	missense
KRAS	NSCLC	12	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Clinical Trials	25516890	RAS type family GTPases	missense
KRAS	NSCLC	13	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Clinical Trials	25516890	RAS type family GTPases	missense
KRAS	NSCLC	61	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Clinical Trials	25516890	RAS type family GTPases	missense
KRAS	OV	12	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Clinical Trials	25500057, 25516890	RAS type family GTPases	missense
KRAS	OV	13	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Clinical Trials	25500057, 25516890	RAS type family GTPases	missense
KRAS	OV	61	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Clinical Trials	25500057, 25516890	RAS type family GTPases	missense
KRAS	PAAD	12	Sensitive	SageDB	gemcitabine + MEK inhibitors	anti-metabolite + MEK inhibitor	Clinical Trials	23583440	RAS type family GTPases	missense
KRAS	PAAD	12	Resistant	SageDB	PI3K pathway inhibitors + MEK inhibitor	PI3K inhibitor + MEK inhibitor	Clinical Trials	ASCO 2015 (abstr 4119)	RAS type family GTPases	missense
KRAS	PAAD	13	Sensitive	SageDB	gemcitabine + MEK inhibitors	anti-metabolite + MEK inhibitor	Clinical Trials	23583440	RAS type family GTPases	missense
KRAS	PAAD	13	Resistant	SageDB	PI3K pathway inhibitors + MEK inhibitor	PI3K inhibitor + MEK inhibitor	Clinical Trials	ASCO 2015 (abstr 4119)	RAS type family GTPases	missense
KRAS	PAAD	61	Sensitive	SageDB	gemcitabine + MEK inhibitors	anti-metabolite + MEK inhibitor	Clinical Trials	23583440	RAS type family GTPases	missense
KRAS	PAAD	61	Resistant	SageDB	PI3K pathway inhibitors + MEK inhibitor	PI3K inhibitor + MEK inhibitor	Clinical Trials	ASCO 2015 (abstr 4119)	RAS type family GTPases	missense
KRAS	STAD	12	Resistant	SageDB	anti-EGFR mAbs	EGFR inhibitor (1st or 2nd gen)	Preclinical	22614881, 22290393	RAS type family GTPases	missense
KRAS	STAD	13	Resistant	SageDB	anti-EGFR mAbs	EGFR inhibitor (1st or 2nd gen)	Preclinical	22614881, 22290393	RAS type family GTPases	missense
KRAS	UCEC	12	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	21984976, 22662154	RAS type family GTPases	missense
KRAS	UCEC	12	Resistant	SageDB	PI3K pathway inhibitors	PI3K inhibitor	Preclinical	22662154	RAS type family GTPases	missense
KRAS	UCEC	13	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	21984976, 22662154	RAS type family GTPases	missense
KRAS	UCEC	13	Resistant	SageDB	PI3K pathway inhibitors	PI3K inhibitor	Preclinical	22662154	RAS type family GTPases	missense
KRAS	UCEC	61	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	21984976, 22662154	RAS type family GTPases	missense
KRAS	UCEC	61	Resistant	SageDB	PI3K pathway inhibitors	PI3K inhibitor	Preclinical	22662154	RAS type family GTPases	missense
LRP1B	OV	Expression	Sensitive	SageDB	liposomal doxorubicin	Antineoplastic	Clinical Trials	22896685	Low density lipoprotein receptors	NOS
MAP2K1	---	115	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	124	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	124	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.D67N	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.E120D	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.F129L	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.F129L	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.F133L	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.G128D	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.H119P	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.I103N	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.I103N	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.I111N	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.I99T	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.K104N	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.L215P	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.L215P	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.Q56P	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	---	p.V211D	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	LAML	p.R49C	Resistant	CancerDR	RDEA119	MEK inhibitor	Preclinical	23486013	Mitogen-activated protein kinase kinases	missense
MAP2K1	NSCLC	p.Y134C	Resistant	CancerDR	CI1040	MEK inhibitor	Preclinical	23486013	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	124	Sensitive	SageDB	MEK inhibitors, ERK inhibitors	MEK inhibitor	Preclinical	25370473	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	124	Resistant	SageDB	BRAF inhibitors	B-Raf inhibitor	Clinical Trials	25370473	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.C121S	Sensitive	SageDB	novel MEK inhibitors	MEK inhibitor	Preclinical	24448821	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.C121S	Resistant	SageDB	BRAF inhibitors, MEK inhibitors	B-Raf inhibitor,MEK inhibitor	Case Reports	21383288	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.E203K	Resistant	SageDB	vemurafenib	B-Raf inhibitor	Case Reports	23569304	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.I111S	Sensitive	SageDB	BRAF inhibitors in BRAF mutant tumor	B-Raf inhibitor	Case Reports	22588879	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.K57E	Resistant	SageDB	vemurafenib	B-Raf inhibitor	Case Reports	23569304	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.K57N	Resistant	SageDB	MEK inhibitors	MEK inhibitor	Case Reports	23444215	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.P124L	Resistant	SageDB	BRAF inhibitors, MEK inhibitors	B-Raf inhibitor,MEK inhibitor	Case Reports	19915144	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.P124S	Sensitive	SageDB	BRAF inhibitors in BRAF mutant tumor	B-Raf inhibitor	Case Reports	22588879	Mitogen-activated protein kinase kinases	missense
MAP2K1	SKCM	p.Q56P	Resistant	SageDB	vemurafenib	B-Raf inhibitor	Case Reports	23569304	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.C125S	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.C125S	Resistant	SageDB	BRAF inhibitors, MEK inhibitors	B-Raf inhibitor,MEK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.L46F	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.L46F	Resistant	SageDB	BRAF inhibitors, MEK inhibitors	B-Raf inhibitor,MEK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.N126D	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.N126D	Resistant	SageDB	BRAF inhibitors, MEK inhibitors	B-Raf inhibitor,MEK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.Q60P	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	24265154	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.Q60P	Resistant	SageDB	BRAF + MEK inhibitors	B-Raf inhibitor + MEK inhibitor	Case Reports	24265154	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.V35M	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAP2K2	SKCM	p.V35M	Resistant	SageDB	BRAF inhibitors, MEK inhibitors	B-Raf inhibitor,MEK inhibitor	Preclinical	24265153	Mitogen-activated protein kinase kinases	missense
MAPK14	LAML	p.E71K	Sensitive	CancerDR	VX702	MAPK inhibitor	Preclinical	23486013	Mitogen-activated protein kinases	missense
MAPK14	NSCLC	p.P322R	Sensitive	CancerDR	BIRB0796	MAPK inhibitor	Preclinical	23486013	Mitogen-activated protein kinases	missense
MAPK8	COADREAD	p.C79Y	Resistant	CancerDR	JNK9L	Not Otherwise Specified	Preclinical	23486013	Mitogen-activated protein kinases	missense
MCL1	---	Expression	Resistant	SageDB	anti-tubulin agents	tubulin inhibitor	Preclinical	21368834	Unspecified	NOS
MDM2	COADREAD	p.C314Y	Resistant	CancerDR	Nutlin3	MDM2 inhibitor	Preclinical	23486013	Zinc fingers, RAN binding-type	missense
MDM2	OV	p.K369fs	Resistant	CancerDR	Nutlin3	MDM2 inhibitor	Preclinical	23486013	Zinc fingers, RAN binding-type	frame_shift_del_unspecified
MDM2	SARC	CNA	Sensitive	SageDB	MDM2 inhibitors (tumors TP53 wt)	MDM2 inhibitor	Clinical Trials	23084521, ASCO 2015 (abstr 10564)	Zinc fingers, RAN binding-type	NOS
MDM4	SARC	CNA	Sensitive	SageDB	MDM2/MDMX inhibitors	MDM2 inhibitor	Preclinical	24336067	Unspecified	NOS
MET	---	p.H1049R	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	---	p.H1112L	Sensitive	SageDB	MET inhibitors	c-Met inhibitor	Preclinical	AACR 2012 (abstr 1786)	Receptor Tyrosine Kinases	missense
MET	---	p.M1250I	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	---	p.R988C	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	---	p.T1010I	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	---	p.V1092I	Sensitive	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	---	p.Y1230C	Resistant	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	---	p.Y1235D	Resistant	SageDB	crizotinib	c-Met inhibitor	Preclinical	17483355	Receptor Tyrosine Kinases	missense
MET	BRCA	CNA	Resistant	SageDB	trastuzumab in HER2-amplified	HER-2 inhibitor	Clinical Trials	22850551	Receptor Tyrosine Kinases	NOS
MET	DLBC	p.D1240N	Sensitive	CancerDR	PHA665752	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
MET	ESCA	p.E815D	Resistant	CancerDR	PF2341066	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
MET	GBM	CNA	Sensitive	SageDB	crizotinib	c-Met inhibitor	Case Reports	22162573	Receptor Tyrosine Kinases	NOS
MET	GBM	any	Sensitive		crizotinib	c-Met inhibitor	Case Reports	27748748	Receptor Tyrosine Kinases	Fusion
MET	KIRC	CNA	Sensitive	SageDB	MET inhibitors	c-Met inhibitor	Clinical Trials	23213094	Receptor Tyrosine Kinases	NOS
MET	KIRC	p.H1094R	Sensitive	SageDB	MET inhibitors	c-Met inhibitor	Clinical Trials	23213094	Receptor Tyrosine Kinases	missense
MET	KIRC	p.M1268T	Sensitive	SageDB	MET inhibitors	c-Met inhibitor	Case Reports	23610116	Receptor Tyrosine Kinases	missense
MET	LAML	p.L530V	Resistant	CancerDR	PHA665752	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
MET	LUAD	CNA	Sensitive	SageDB	crizotinib	c-Met inhibitor	Clinical Trials	ASCO 2014 (abstr 8001), ASCO 2015 (abstr 2595)	Receptor Tyrosine Kinases	NOS
MET	LUAD	CNA	Resistant	SageDB	EGFR TKIs (EGFR mutant disease)	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	ASCO 2015 (abstr 8089)	Receptor Tyrosine Kinases	NOS
MET	NSCLC	CNA	Resistant	MyCancerGenome	EGFR TKIs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	18093943	Receptor Tyrosine Kinases	NOS
MET	NSCLC	p.V941L	Resistant	CancerDR	PHA665752	c-Met inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
MET	STAD	CNA	Sensitive	SageDB	MET inhibitors	c-Met inhibitor	Case Reports	22042947, ASCO GI 2015 (abstr 1)	Receptor Tyrosine Kinases	NOS
MET	STAD	CNA	Resistant	SageDB	lapatinib in HER2-amplified	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	22238368	Receptor Tyrosine Kinases	NOS
MGMT	GBM	CNL	Sensitive	SageDB	temozolomide	Antineoplastic	Clinical Trials	15758010	Unspecified	NOS
MITF	SKCM	CNA	Resistant	SageDB	BRAF inhibitors	B-Raf inhibitor	Case Reports	24265153	Basic helix-loop-helix proteins	NOS
MLL	LAML	any	Sensitive	SageDB	daunorubicin	Topoisomerase inhibitor	FDA Approved	22417203	Unspecified	Fusion
MPL	MPD	p.W515F	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	16834459	Fibronectin type III domain containing	missense
MS4A1	CLL	Expression	Sensitive	MyCancerGenome	anti-CD20	CD20 inhibitor	FDA Approved	20194866	CD molecules	NOS
MS4A1	DLBC	Expression	Sensitive	MyCancerGenome	anti-CD20	CD20 inhibitor	FDA Approved	16648042	Unspecified	NOS
MTOR	---	p.F2108L	Sensitive	SageDB	mTOR kinase inhibitors	mTOR inhibitor	Preclinical	25295501	GO Protein Kinase	missense
MTOR	---	p.L1460P	Sensitive	SageDB	rapamycin	mTOR inhibitor	Preclinical	24631838	GO Protein Kinase	missense
MTOR	---	p.R2505P	Sensitive	SageDB	rapamycin	mTOR inhibitor	Preclinical	24631838	GO Protein Kinase	missense
MTOR	---	p.S2215Y	Sensitive	SageDB	rapamycin	mTOR inhibitor	Preclinical	24631838	GO Protein Kinase	missense
MTOR	BLCA	p.E2014K	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	24625776	GO Protein Kinase	missense
MTOR	BLCA	p.E2419K	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	24625776	GO Protein Kinase	missense
MTOR	BLCA	p.N1421D	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	ASCO 2015 (abstr 11010)	GO Protein Kinase	missense
MTOR	GBM	p.R1208C	Resistant	CancerDR	AZD8055	mTOR inhibitor	Preclinical	23486013	GO Protein Kinase	missense
MTOR	KIRC	p.Q2223K	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	24622468	GO Protein Kinase	missense
MTOR	NSCLC	p.A1134V	Resistant	CancerDR	AZD8055	mTOR inhibitor	Preclinical	23486013	GO Protein Kinase	missense
MTOR	SARC	p.I1973F	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	ASCO 2015 (abstr 11010)	GO Protein Kinase	missense
MTOR	SKCM	p.P453L	Resistant	CancerDR	AZD8055	mTOR inhibitor	Preclinical	23486013	GO Protein Kinase	missense
MTOR	SKCM	p.R2152C	Resistant	CancerDR	Temsirolim	mTOR inhibitor	Preclinical	23486013	GO Protein Kinase	missense
MTOR	STAD	p.K1771R	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	ASCO 2015 (abstr 11010)	GO Protein Kinase	missense
MTOR	THCA	p.F2108L	Resistant	SageDB	everolimus	mTOR inhibitor	Case Reports	25295501	GO Protein Kinase	missense
MYC	MM	CNA	Sensitive	SageDB	BET inhibitors	BET inhibitor	Preclinical	21889194	Basic helix-loop-helix proteins	NOS
MYC	NB	CNA	Sensitive	SageDB	CDK7 inhibitors	CDK inhibitor	Preclinical	25416950	Basic helix-loop-helix proteins	NOS
MYC	PRAD	CNA	Sensitive	SageDB	PIM inhibitors	Pim-1 inhibitor	Preclinical	25505253	Basic helix-loop-helix proteins	NOS
MYCN	MM	CNA	Sensitive	SageDB	BET inhibitors	BET inhibitor	Preclinical	21889194	Basic helix-loop-helix proteins	NOS
MYCN	NB	CNA	Sensitive	SageDB	BET inhibitors	BET inhibitor	Preclinical	23430699	Basic helix-loop-helix proteins	NOS
MYD88	DLBC	p.L265P	Sensitive	SageDB	JAK inhibitors	JAK kinase inhibitor	Preclinical	21179087	Unspecified	missense
NF1	GBM	CNL	Sensitive	SageDB	mTOR inhibitors	mTOR inhibitor	Preclinical	19573811	Unspecified	NOS
NF1	HNSC	p.D1644A	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	ASCO 2015 (abstr 11010)	Unspecified	missense
NF1	MPNST	CNL	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	23221341,  23858101	Unspecified	NOS
NF1	SKCM	CNL	Resistant	SageDB	MEK inhibitors in BRAF mutant tumors	MEK inhibitor	Case Reports	23444215, 23288408	Unspecified	NOS
NF2	MESO	CNL	Sensitive	SageDB	FAK inhibitors	FAK inhibitor	Clinical Trials	ENA 2012 (abstr 610)	A-kinase anchor proteins	NOS
NF2	MESO	Expression	Resistant	MyCancerGenome	FAK inhibitor	FAK inhibitor	Preclinical	24848258	A-kinase anchor proteins	NOS
NF2	MPNST	CNL	Sensitive	SageDB	PAK inhibitors	PAK inhibitor	Clinical Trials	23960073	A-kinase anchor proteins	NOS
NF2	OV	Expression	Resistant	MyCancerGenome	FAK inhibitor	FAK inhibitor	Preclinical	24786638	A-kinase anchor proteins	NOS
NOTCH1	ALL	any	Sensitive	SageDB	Gamma secretase inhibitors	Gamma secretease inhibitor	Preclinical	16688224, 23033986	Ankyrin repeat domain containing	Fusion
NOTCH1	ALL	exon p.1529-1723	Sensitive	SageDB	steroids early setting	steroid	Clinical Trials	20861909, 20861920, 20944675	Ankyrin repeat domain containing	missense
NOTCH1	ALL	exon p.2245-2536	Sensitive	SageDB	steroids early setting	steroid	Clinical Trials	20861909, 20861920, 20944675	Ankyrin repeat domain containing	missense
NOTCH1	BRCA	any	Sensitive	SageDB	Gamma secretase inhibitors	Gamma secretease inhibitor	Preclinical	22101766	Ankyrin repeat domain containing	Fusion
NOTCH1	BRCA	exon p.2245-2536	Sensitive	SageDB	Gamma secretase inhibitors	Gamma secretease inhibitor	Preclinical	25564152	Ankyrin repeat domain containing	missense
NOTCH2	BRCA	any	Sensitive	SageDB	Gamma secretase inhibitors	Gamma secretease inhibitor	Preclinical	22101766	Ankyrin repeat domain containing	Fusion
NOTCH2	BRCA	exon p.2010-2472	Sensitive	SageDB	Gamma secretase inhibitors	Gamma secretease inhibitor	Preclinical	25564152	Ankyrin repeat domain containing	missense
NPM-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
NRAS	---	p.G12C	Sensitive	SageDB	ERK inhibitors	ERK inhibitor	Preclinical	23614898	RAS type family GTPases	missense
NRAS	ALL	12	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	18701506	RAS type family GTPases	missense
NRAS	ALL	13	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	18701506	RAS type family GTPases	missense
NRAS	ALL	61	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	18701506	RAS type family GTPases	missense
NRAS	COADREAD	12	Sensitive	SageDB	MEK inhibitors +/- PI3K pathway inhibitors	MEK inhibitor, PI3K inhibitor, MEK inhibitor + PI3K inhibitor	Preclinical	23274911, 22392911	RAS type family GTPases	missense
NRAS	COADREAD	12	Resistant	SageDB	cetuximab, panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839, 20619739, 23325582	RAS type family GTPases	missense
NRAS	COADREAD	13	Sensitive	SageDB	MEK inhibitors +/- PI3K pathway inhibitors	MEK inhibitor, PI3K inhibitor, MEK inhibitor + PI3K inhibitor	Preclinical	23274911, 22392911	RAS type family GTPases	missense
NRAS	COADREAD	13	Resistant	SageDB	cetuximab, panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839, 20619739, 23325582	RAS type family GTPases	missense
NRAS	COADREAD	61	Sensitive	SageDB	MEK inhibitors +/- PI3K pathway inhibitors	MEK inhibitor, PI3K inhibitor, MEK inhibitor + PI3K inhibitor	Preclinical	23274911, 22392911	RAS type family GTPases	missense
NRAS	COADREAD	61	Resistant	SageDB	cetuximab, panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	24024839, 20619739, 23325582	RAS type family GTPases	missense
NRAS	COADREAD	Wild Type	Sensitive	SageDB	cetuximab, panitumumab	EGFR inhibitor (1st or 2nd gen)	FDA Approved	20619739	RAS type family GTPases	NOS
NRAS	COADREAD	p.G12A	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	COADREAD	p.G12C	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	COADREAD	p.G12D	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	COADREAD	p.G12S	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	COADREAD	p.G12V	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	COADREAD	p.Q61K	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	COADREAD	p.Q61R	Resistant	MyCancerGenome	EGFR monoclonal antibodies	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	20619739	RAS type family GTPases	missense
NRAS	LAML	12	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	22507781	RAS type family GTPases	missense
NRAS	LAML	13	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	22507781	RAS type family GTPases	missense
NRAS	LAML	61	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	22507781	RAS type family GTPases	missense
NRAS	LUAD	12	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	23515407	RAS type family GTPases	missense
NRAS	LUAD	13	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	23515407	RAS type family GTPases	missense
NRAS	LUAD	61	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Preclinical	23515407	RAS type family GTPases	missense
NRAS	MM	12	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	22985491	RAS type family GTPases	missense
NRAS	MM	13	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	22985491	RAS type family GTPases	missense
NRAS	MM	61	Sensitive	SageDB	PI3K pathway inhibitors + MEK inhibitors	PI3K inhibitor + MEK inhibitor	Preclinical	22985491	RAS type family GTPases	missense
NRAS	SKCM	61	Sensitive	SageDB	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRAS	SKCM	61	Resistant	SageDB	BRAF inhibitors	B-Raf inhibitor	Case Reports	23569304	RAS type family GTPases	missense
NRAS	SKCM	p.Q61E	Sensitive	MyCancerGenome	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRAS	SKCM	p.Q61H	Sensitive	MyCancerGenome	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRAS	SKCM	p.Q61K	Sensitive	MyCancerGenome	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRAS	SKCM	p.Q61L	Sensitive	MyCancerGenome	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRAS	SKCM	p.Q61P	Sensitive	MyCancerGenome	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRAS	SKCM	p.Q61R	Sensitive	MyCancerGenome	MEK inhibitors	MEK inhibitor	Clinical Trials	23414587	RAS type family GTPases	missense
NRG1	LUAD	any	Sensitive	SageDB	lapatinib	HER-2 inhibitor, EGFR inhibitor (1st or 2nd gen)	Preclinical	24727320	I-set domain containing	Fusion
NTRK1	COADREAD	any	Sensitive	SageDB	pan-TRK inhibitor	Trk inhibitor	Case Reports	ASCO 2015 (abstr 2517)	Receptor Tyrosine Kinases	Fusion
NTRK1	LUAD	any	Sensitive	SageDB	crizotinib	c-Met inhibitor	Case Reports	ASCO 2013 (abstr 8023)	Receptor Tyrosine Kinases	Fusion
NTRK1	NSCLC	p.R748W	Resistant	CancerDR	CEP701	FLT3 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
NTRK3	BRCA	any	Sensitive	SageDB	midostaurin, IGF1R inhibitors, PI3K pathway inhibitors	FLT3 inhibitor,IGF-1R inhibitor, PI3K inhibitor	Preclinical	21148487, 23131561	Receptor Tyrosine Kinases	Fusion
NUP214-ABL1	ALL	any	Sensitive	PCT	imatinib	KIT inhibitor	Clinical Trials	16213363	Unspecified	Fusion
PAK1	SKCM	Expression	Sensitive	SageDB	PAK inhibitors	PAK inhibitor	Preclinical	23535073	STE	NOS
PARP1	SKCM	p.P850L	Sensitive	CancerDR	AZD2281	PARP inhibitor	Preclinical	23486013	Zinc fingers, PARP-type	missense
PDGFRA	COADREAD	p.N848I	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRA	GBM	Expression	Resistant	SageDB	PDGFR inhibitors	Angiogenesis inhibitor	Preclinical	23544171	Receptor Tyrosine Kinases	NOS
PDGFRA	GIST	Wild Type	Sensitive	SageDB	sunitinib	Angiogenesis inhibitor	Clinical Trials	18955458	Receptor Tyrosine Kinases	NOS
PDGFRA	GIST	Wild Type	Resistant	SageDB	imatinib	KIT inhibitor	Clinical Trials	14645423, 18955458	Receptor Tyrosine Kinases	NOS
PDGFRA	GIST	exon p.552-596	Sensitive	MyCancerGenome	imatinib	KIT inhibitor	Clinical Trials	ASCO 2010, abstract 10006; 14645423	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	exon p.631-668	Sensitive	MyCancerGenome	imatinib	KIT inhibitor	Clinical Trials	ASCO 2010; abstract 10006	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	exon p.814-854	Sensitive	MyCancerGenome	imatinib	KIT inhibitor	Clinical Trials	ASCO 2010; abstract 10006	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	p.D842V	Sensitive	SageDB	dasatinib	KIT inhibitor	Preclinical	18794084	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	p.D842V	Resistant	SageDB	imatinib, sunitinib	KIT inhibitor,Angiogenesis inhibitor	Preclinical	22718859, 16638875	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	p.D846Y	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	15928335	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	p.N848K	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	15928335	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	p.V561D	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	17087936	Receptor Tyrosine Kinases	missense
PDGFRA	GIST	p.Y849K	Sensitive	PCT	Imatinib, TKIs	KIT inhibitor	Case Reports	15928335	Receptor Tyrosine Kinases	missense
PDGFRA	HES	any	Sensitive	SageDB	imatinib	KIT inhibitor	FDA Approved	16089297	Receptor Tyrosine Kinases	Fusion
PDGFRA	LAML	p.T124fs	Sensitive	CancerDR	Axitinib	KIT inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	frame_shift_del_unspecified
PDGFRA	LAML	p.T124fs	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	frame_shift_del_unspecified
PDGFRA	MPD	any	Sensitive	SageDB	imatinib	KIT inhibitor	FDA Approved	16089297	Receptor Tyrosine Kinases	Fusion
PDGFRA	MPD	p.T674I	Resistant	SageDB	imatinib	KIT inhibitor	Case Reports	12660384	Receptor Tyrosine Kinases	missense
PDGFRA	NSCLC	p.Y98*	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	nonsense
PDGFRA	PRAD	p.E241D	Sensitive	CancerDR	AMG706	KIT inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRA	SKCM	p.G853D	Sensitive	SageDB	imatinib, crenolanib	KIT inhibitor,FLT3 inhibitor	Preclinical	24132921	Receptor Tyrosine Kinases	missense
PDGFRA	SKCM	p.H845Y	Sensitive	SageDB	imatinib, crenolanib	KIT inhibitor,FLT3 inhibitor	Preclinical	24132921	Receptor Tyrosine Kinases	missense
PDGFRA	SKCM	p.P577S	Sensitive	SageDB	imatinib, crenolanib	KIT inhibitor,FLT3 inhibitor	Preclinical	24132921	Receptor Tyrosine Kinases	missense
PDGFRA	SKCM	p.R841K	Sensitive	SageDB	imatinib, crenolanib	KIT inhibitor,FLT3 inhibitor	Preclinical	24132921	Receptor Tyrosine Kinases	missense
PDGFRA	SKCM	p.V658A	Sensitive	SageDB	crenolanib	FLT3 inhibitor	Preclinical	24132921	Receptor Tyrosine Kinases	missense
PDGFRA	SKCM	p.V658A	Resistant	SageDB	imatinib	KIT inhibitor	Preclinical	24132921	Receptor Tyrosine Kinases	missense
PDGFRA	UCEC	p.T266P	Sensitive	CancerDR	Pazopanib	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRB	BRCA	p.T882I	Sensitive	CancerDR	Pazopanib	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRB	GBM	p.E1069K	Resistant	CancerDR	Sorafenib	Angiogenesis inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRB	LAML	p.T88I	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRB	MPD	any 	Sensitive		imatinib	KIT inhibitor	FDA Approved	24687085	Receptor Tyrosine Kinases	Fusion
PDGFRB	NSCLC	p.G181V	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRB	NSCLC	p.L883M	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDGFRB	UCEC	p.D166G	Sensitive	CancerDR	TKI258	FGFR inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
PDPK1	BRCA	Expression	Sensitive	SageDB	PI3K pathway inhibitors	PI3K inhibitor	Preclinical	19602588	GO Protein Kinase	NOS
PGR	BRCA	Expression	Sensitive	MyCancerGenome	SERM, SERD, or AI	anti-estrogen	FDA Approved	12743151	Nuclear hormone receptors	NOS
PIK3CA	BRCA	CNA	Resistant	SageDB	PI3K pathway inhibitors	PI3K inhibitor	Preclinical	24366379	Phosphatidylinositol 3-kinase subunits	NOS
PIK3CA	COADREAD	p.E542K	Sensitive	MyCancerGenome	mTOR inhibitors	mTOR inhibitor	Preclinical	21358673	Phosphatidylinositol 3-kinase subunits	missense
PIK3CA	COADREAD	p.E545K	Sensitive	MyCancerGenome	mTOR inhibitors	mTOR inhibitor	Preclinical	21358673	Phosphatidylinositol 3-kinase subunits	missense
PIK3CA	COADREAD	p.H1047R	Sensitive	MyCancerGenome	PI3K/AKT/mTOR inhibitors	PI3K inhibitor, AKT inhibitor, mTOR inhibitor	Clinical Trials	23066039	Phosphatidylinositol 3-kinase subunits	missense
PIK3CB	PRAD	p.A686T	Resistant	CancerDR	NVPBEZ235	PI3K inhibitor	Preclinical	23486013	Phosphatidylinositol 3-kinase subunits	missense
PIK3CG	BRCA	p.Y672*	Resistant	CancerDR	NVPBEZ235	PI3K inhibitor	Preclinical	23486013	Phosphatidylinositol 3-kinase subunits	nonsense
PIK3CG	PAAD	p.T827R	Resistant	CancerDR	NVPBEZ235	PI3K inhibitor	Preclinical	23486013	Phosphatidylinositol 3-kinase subunits	missense
PIK3R2	UCEC	p.A171V	Sensitive	SageDB	mTOR inhibitors	mTOR inhibitor	Preclinical	21984976, 19962665	SH2 domain containing	missense
PIK3R2	UCEC	p.N561D	Sensitive	SageDB	mTOR inhibitors	mTOR inhibitor	Preclinical	21984976	SH2 domain containing	missense
PLCG2	CLL	p.L845F	Resistant	SageDB	ibrutinib	BTK inhibitor	Clinical Trials	24869598	SH2 domain containing	missense
PLCG2	CLL	p.R665W	Resistant	SageDB	ibrutinib	BTK inhibitor	Clinical Trials	24869598	SH2 domain containing	missense
PLK1	COADREAD	p.S107N	Resistant	CancerDR	BI2536	Plk-1 inhibitor	Preclinical	23486013	Other	missense
PLK2	COADREAD	p.D560V	Resistant	CancerDR	BI2536	Plk-1 inhibitor	Preclinical	23486013	Other	missense
PML-RARA	LAML	any	Sensitive	SageDB	ATRA + arsenic trioxide	retinoid + Antineoplastic	FDA Approved	15103387	Unspecified	Fusion
PRKCE	LAML	p.P507A	Sensitive	CancerDR	Bryostatin	macrolide	Preclinical	23486013	C2 domain containing protein kinases	missense
PRKCE	NSCLC	p.E149K	Sensitive	CancerDR	Bryostatin	macrolide	Preclinical	23486013	C2 domain containing protein kinases	missense
PRKCH	CML	Expression	Sensitive	SageDB	trametinib (plus imatinib in BCR-ABL)	MEK inhibitor + KIT inhibitor	Preclinical	25186176	C2 domain containing protein kinases	NOS
PRKCSH	SKCM	p.E325in_frame_del	Sensitive	CancerDR	Bryostatin	macrolide	Preclinical	23486013	EF-hand domain containing	in_frame_del
PRKDC	BLCA	p.L1244fs	Sensitive	CancerDR	NU7441	DNA-PK inhibitor	Preclinical	23486013	GO Protein Kinase	frame_shift_del_unspecified
PRKDC	LAML	p.L1244fs	Sensitive	CancerDR	NU7441	DNA-PK inhibitor	Preclinical	23486013	GO Protein Kinase	frame_shift_del_unspecified
PRKDC	MPNST	p.L1244fs	Sensitive	CancerDR	NU7441	DNA-PK inhibitor	Preclinical	23486013	GO Protein Kinase	frame_shift_del_unspecified
PRKDC	NSCLC	p.L1244fs	Sensitive	CancerDR	NU7441	DNA-PK inhibitor	Preclinical	23486013	GO Protein Kinase	frame_shift_del_unspecified
PRKDC	SKCM	p.L1244fs	Sensitive	CancerDR	NU7441	DNA-PK inhibitor	Preclinical	23486013	GO Protein Kinase	frame_shift_del_unspecified
PTCH1	MB	CNL	Sensitive	PCT	vismodegib	SMO inhibitor	Case Reports	26169613	Unspecified	NOS
PTEN	BRCA	CNL	Resistant	SageDB	PI3K alpha inhibitors	PI3K inhibitor	Clinical Trials	25409150	PTEN protein phosphatases	NOS
PTEN	COADREAD	Underexpression	Resistant	SageDB	anti-EGFR mAbs	EGFR inhibitor (1st or 2nd gen)	Clinical Trials	21163703, 19398573	PTEN protein phosphatases	NOS
PTEN	NSCLC	CNL	Sensitive	SageDB	PI3K pathway inhibitors (alone or in combination)	PI3K inhibitor	Preclinical	23136191	PTEN protein phosphatases	NOS
PTEN	PAAD	CNL	Sensitive	SageDB	AKT inhibitors	AKT inhibitor	Case Reports	22025163	PTEN protein phosphatases	NOS
PTEN	PRAD	CNL	Sensitive	SageDB	everolimus	mTOR inhibitor	Clinical Trials	23582881	PTEN protein phosphatases	NOS
PTEN	SKCM	CNL	Resistant	SageDB	BRAF inhibitors in BRAF mutant tumor	B-Raf inhibitor	Preclinical	21317224, 21725359	PTEN protein phosphatases	NOS
PTEN	UCEC	CNL	Sensitive	SageDB	PARP inhibitors	PARP inhibitor	Case Reports	21468130, 20944090	PTEN protein phosphatases	NOS
PTPN11	GBM	p.R498W	Sensitive	CancerDR	NSC87877	Shp-1 inhibitor	Preclinical	23486013	SH2 domain containing	missense
RAC1	SKCM	p.P29S	Resistant	SageDB	BRAF inhibitors in BRAF mutant tumors	B-Raf inhibitor	Case Reports	25056119	Rho family GTPases	missense
RAD50	NEC	p.L1237F	Sensitive	SageDB	irinotecan plus CHK1/2 inhibitor in ATM deficient tumor	Topoisomerase inhibitor + CHK1/2 inhibitor	Case Reports	24934408	Unspecified	missense
RAF1	PRAD	any	Sensitive	SageDB	sorafenib, MEK inhibitors	Angiogenesis inhibitor,MEK inhibitor	Preclinical	20526349	TKL	Fusion
RAF1	SKCM	p.G361A	Resistant	SageDB	BRAF inhibitors in BRAF mutant tumors	B-Raf inhibitor	Preclinical	23737487	TKL	missense
RAF1	SKCM	p.S257P	Resistant	SageDB	BRAF inhibitors in BRAF mutant tumors	B-Raf inhibitor	Preclinical	23737487	TKL	missense
RANBP2-ALK	NSCLC	any	Sensitive	PCT	Crizotinib	c-Met inhibitor	Case Reports	27494825	Unspecified	Fusion
RB1	SKCM	CNL	Resistant	SageDB	BRAF inhibitors in BRAF mutant tumor	B-Raf inhibitor	Preclinical	21725359	Endogenous ligands	NOS
RCSD1-ABL1	ALL	any	Resistant	PCT	dasatinib	KIT inhibitor	Case Reports	21863287	Unspecified	Fusion
RET	COADREAD	p.A45T	Resistant	CancerDR	CEP701	FLT3 inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
RET	LUAD	any	Sensitive	SageDB	cabozantinib, vandetanib	Angiogenesis inhibitor,RET inhibitor	Clinical Trials	23533264, 23584301, 25366691, ASCO 2015 (abstr 8007)	Receptor Tyrosine Kinases	Fusion
RET	PRAD	p.L746M	Sensitive	CancerDR	AMG706	KIT inhibitor	Preclinical	23486013	Receptor Tyrosine Kinases	missense
RET	TGCT	CNA	Sensitive	PCT	sunitinib	Angiogenesis inhibitor	Case Reports	25085632	Receptor Tyrosine Kinases	NOS
RET	THCA	618	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	620	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	634	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	768	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	791	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	804	Sensitive	PCT	sorafenib	Angiogenesis inhibitor	Clinical Trials	20368568	Receptor Tyrosine Kinases	missense
RET	THCA	891	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	918	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	p.C634F	Sensitive	PCT	sorafenib	Angiogenesis inhibitor	Clinical Trials	20368568	Receptor Tyrosine Kinases	missense
RET	THCA	p.C634R	Sensitive	PCT	sorafenib	Angiogenesis inhibitor	Clinical Trials	20368568	Receptor Tyrosine Kinases	missense
RET	THCA	p.C634W	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET	THCA	p.C634Y	Sensitive	PCT	sorafenib	Angiogenesis inhibitor	Clinical Trials	20368568	Receptor Tyrosine Kinases	missense
RET	THCA	p.M918T	Sensitive	SageDB	vandetanib	RET inhibitor	FDA Approved	20065189, 22025146	Receptor Tyrosine Kinases	missense
RET-PTC1	THCA	any	Sensitive	SageDB	RET inhibitors	RET inhibitor	Preclinical	23056499	Unspecified	Fusion
ROS1	IMT	any	Sensitive	SageDB	crizotinib	c-Met inhibitor	Case Reports	24875859	Receptor Tyrosine Kinases	Fusion
ROS1	LUAD	any	Sensitive	SageDB	crizotinib	c-Met inhibitor	Clinical Trials	25264305	Receptor Tyrosine Kinases	Fusion
ROS1	LUAD	p.G2032R	Sensitive	SageDB	cabozantinib	Angiogenesis inhibitor	Preclinical	25351743	Receptor Tyrosine Kinases	missense
ROS1	LUAD	p.G2032R	Resistant	SageDB	crizotinib	c-Met inhibitor	Case Reports	23724914, 25688157	Receptor Tyrosine Kinases	missense
ROS1	NSCLC	any	Sensitive	MyCancerGenome	crizotinib (ALK/MET/ROS1 TKI)	c-Met inhibitor	FDA Approved	25264305	Receptor Tyrosine Kinases	Fusion
RPS6KA2	LAML	p.A657S	Sensitive	CancerDR	CMK	Not Otherwise Specified	Preclinical	23486013	GO Protein Kinase	missense
RPS6KA4	BRCA	p.S236L	Sensitive	CancerDR	SL01011	Not Otherwise Specified	Preclinical	23486013	GO Protein Kinase	missense
RPS6KA6	COADREAD	p.R310S	Resistant	CancerDR	CMK	Not Otherwise Specified	Preclinical	23486013	GO Protein Kinase	missense
SF3B1	---	p.K700E	Sensitive	SageDB	spliceosome inhibitor	spliceosome inhibitor	Preclinical	ENA 2014 (abstr 456), ENA 2014 (abstr 575)	Unspecified	missense
SMARCB1	SARC	CNL	Sensitive	MyCancerGenome	EZH inhibitors	---	Preclinical	23620515	Unspecified	NOS
SMO	BCC	p.A459V	Resistant	MyCancerGenome	Vismodegib	SMO inhibitor	Case Reports	25759019	G protein-coupled receptors, Class F frizzled	missense
SMO	BCC	p.D473Y	Resistant	MyCancerGenome	Vismodegib	SMO inhibitor	Case Reports	25306392	G protein-coupled receptors, Class F frizzled	missense
SMO	BCC	p.G497W	Resistant	MyCancerGenome	Vismodegib	SMO inhibitor	Case Reports	25306392	G protein-coupled receptors, Class F frizzled	missense
SMO	BCC	p.V321M	Resistant	MyCancerGenome	Vismodegib	SMO inhibitor	Case Reports	25199678	G protein-coupled receptors, Class F frizzled	missense
SMO	BCC	p.W281L	Resistant	MyCancerGenome	Vismodegib	SMO inhibitor	Case Reports	25199678	G protein-coupled receptors, Class F frizzled	missense
SMO	MB	p.D473H	Resistant	SageDB	vismodegib	SMO inhibitor	Case Reports	19726788, 25759019	G protein-coupled receptors, Class F frizzled	missense
SQSTM1-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
SRC	COADREAD	p.V380M	Resistant	CancerDR	AZD0530	Bcr-Abl TKI	Preclinical	23486013	SH2 domain containing	missense
STK11	LUAD	CNL	Sensitive	SageDB	phenformin	Antidiabetic Drug	Preclinical	23352126	GO Protein Kinase	NOS
STK11	LUAD	CNL	Resistant	SageDB	MEK inhibitors + docetaxel in KRAS mutant	MEK inhibitor, Antineoplastic	Preclinical	22425996	GO Protein Kinase	NOS
STK11	PAAD	p.D194E	Sensitive	SageDB	everolimus	mTOR inhibitor	Case Reports	21189378	GO Protein Kinase	missense
SUZ12	---	CNL	Sensitive	SageDB	BET inhibitors	BET inhibitor	Preclinical	25119042	Zinc fingers, C2H2-type	NOS
SYK	CLL	Expression	Sensitive	SageDB	SYK inhibitors	Syk inhibitor	Preclinical	16409295, 19549911	SH2 domain containing	NOS
TFG-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
TMPRSS2	PRAD	any	Sensitive	SageDB	DNA-PKc inhibitors	DNA-PK inhibitor	Preclinical	21575865	Proteases, serine	Fusion
TOP2A	BRCA	CNA	Sensitive	SageDB	anthracyclines	Topoisomerase inhibitor	Clinical Trials	22864769	Unspecified	NOS
TPM3-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
TPM4-ALK	NSCLC	any	Sensitive	PCT	Crizotinib, Ceritinib	c-Met inhibitor,ALK inhibitor	FDA Approved	23724913	Unspecified	Fusion
TRIM33-RET	LUAD	any	Sensitive	PCT	cabozantinib	Angiogenesis inhibitor	Case Reports	23533264	Unspecified	Fusion
VEGFA	LIHC	CNA	Sensitive	SageDB	sorafenib	Angiogenesis inhibitor	Clinical Trials	24687604	Unspecified	NOS
KRAS	NSCLC	12	Sensitive	NA	CDK4/6 inhibitor + MEK inhibitors	CDK4/6 inhibitor + MEK inhibitors	Clinical Trials	AACR 2017 (abstr CT046)	RAS type family GTPases	missense
KRAS	NSCLC	13	Sensitive	NA	CDK4/6 inhibitor + MEK inhibitors	CDK4/6 inhibitor + MEK inhibitors	Clinical Trials	AACR 2017 (abstr CT046)	RAS type family GTPases	missense
KRAS	NSCLC	61	Sensitive	NA	CDK4/6 inhibitor + MEK inhibitors	CDK4/6 inhibitor + MEK inhibitors	Clinical Trials	AACR 2017 (abstr CT046)	RAS type family GTPases	missense
NRAS	SKCM	12	Sensitive	NA	CDK4/6 inhibitor + MEK inhibitors	CDK4/6 inhibitor + MEK inhibitors	Clinical Trials	26658964	RAS type family GTPases	missense
NRAS	SKCM	13	Sensitive	NA	CDK4/6 inhibitor + MEK inhibitors	CDK4/6 inhibitor + MEK inhibitors	Clinical Trials	26658964	RAS type family GTPases	missense
NRAS	SKCM	61	Sensitive	NA	CDK4/6 inhibitor + MEK inhibitors	CDK4/6 inhibitor + MEK inhibitors	Clinical Trials	26658964	RAS type family GTPases	missense
